Publications of the BioVentures Institute scientists with Impact Factor listing

2016

362. Zylicz-Stachula A, Zebrowska J, Czajkowska E, Wrese W, Sulecka E, Skowron PM. Engineering TaqII bifunctional endonuclease DNA recognition fidelity: the effect of a single amino acid substitution within the methyltransferase catalytic site. Molecular Biology Reports 2016, DOI 10.1007/s11033-016-3949-3. IF(2015/2016) = 1.698

361. Zebrowska J, Zołnierkiewicza O, Skowron MA, Zylicz-Stachula A, Jezewska-Frackowiak J, Skowron PM. Subtype IIS restriction endonuclease GeoICI from Geobacillus sp. – a robust, thermostable alternative to mezophilic prototype BbvI. Journal of Biosciences 2016, DOI 10.1007/s12038-016-9595-z. IF(2015/2016) = 1.419

 

2015

360. Skowron MA, Zebrowska J, Wegrzyn GSkowron PMMmoSTI restriction endonuclease, isolated fromMorganella morganii infecting a tropical moth, Actias selene, cleaving 5’-|CCNGG-3’ sequences. J Appl Genetics 2015, DOI 10.1007/s13353-015-0308-3. IF(2015/2016) = 1.929

359. Krefft D, Zylicz-Stachula A, Mulkiewicz E, Papkov A, Jezewska-Frackowiak J, Skowron PM. Two-stage gene assembly/cloning of a member of the TspDTI subfamily of bifunctional restriction endonucleases, TthHB27I. J Biotechnol. 2015 Jan 20;194:67-80. doi: 10.1016/j.jbiotec.2014.11.030.  IF(2013/2014) = 2.884

358. Jezewska-Frackowiak J, Lubys A, Vitkute J, Zakareviciene L, Zebrowska J, Krefft D, Skowron MA, Zylicz-Stachula A, Skowron PM. A new prototype IIS/IIC/IIG endonuclease-methyltransferase TsoI from the thermophile Thermus scotoductus, recognising 5'-TARCCA(N11/9)-3' sequences. J Biotechnol. 2015 Jan 20;194:19-26. doi: 10.1016/j.jbiotec.2014.11.023.  IF(2013/2014) = 2.884

357. Nejman-Faleńczyk B, Bloch S, Licznerska K, Dydecka A, Felczykowska A, Topka G, Węgrzyn A, Węgrzyn GA small, microRNA-size, ribonucleic acid regulating gene expression and development of Shiga toxin-converting bacteriophage Φ24Β.Sci Rep. 2015 May 11;5:10080. doi: 10.1038/srep10080. IF(2013/2014) = 5.078

356. Moskot M, Jakóbkiewicz-Banecka J, Kloska A, Smolińska E, Mozolewski P, Malinowska M, Rychłowski M, Banecki B, Węgrzyn G, Gabig-Cimińska M. Modulation of expression of genes involved in glycosaminoglycan metabolism and lysosome biogenesis by flavonoids. Sci Rep. 2015 Mar 23;5:9378. doi: 10.1038/srep09378. IF(2013/2014) = 5.078

355. Nowicki D, Bloch S, Nejman-Falenczyk B, Szalewska-Palasz A, Wegrzyn A, Wegrzyn GDefects in RNA polyadenylation impair both lysogenization by and lytic development of Shiga toxin-converting bacteriophagesJ Gen Virol. 2015 Feb 23. pii: vir.0.000102. doi: 10.1099/vir.0.000102. IF(2013/2014) = 3.529

354. Sokołowska I, Piłka ES, Sandvig K, Węgrzyn G, Słomińska-Wojewódzka M. Hydrophobicity of protein determinants influences the recognition of substrates by EDEM1 and EDEM2 in human cellsBMC Cell Biol. 2015 Feb 6;16:1. doi: 10.1186/s12860-015-0047-7. IF(2013/2014) = 2.844

353. Konieczna A, Szczepańska A, Sawiuk K, Łyżeń R, Węgrzyn GEnzymes of the central carbon metabolism: are they linkers between transcription, DNA replication, and carcinogenesis? Med Hypotheses. 2015 Jan;84(1):58-67. doi: 10.1016/j.mehy.2014.11.016. Epub 2014 Dec 1. IF(2013/2014) = 1.152

352. Cayrol B, Fortas E, Martret C, Cech G, Kloska A, Caulet S, Barbet M, Trépout S, Marco S, Taghbalout A, Busi F, Wegrzyn G, Arluison V. Riboregulation of the bacterial actin-homolog MreB by DsrA small noncoding RNA. Integr Biol (Camb). 2015 Jan;7(1):128-41. doi: 10.1039/c4ib00102h. IF(2013/2014) = 3.996

2014

351. Bloch S, Nejman-Faleńczyk B, Dydecka A, Loś JM, Felczykowska A, Węgrzyn A, Węgrzyn G: Different Expression Patterns of Genes from the Exo-Xis Region of Bacteriophage λ and Shiga Toxin-Converting Bacteriophage Ф24B following Infection or Prophage Induction in Escherichia coli. PLoS One. 2014 Oct 13;9(10):e108233. doi: 10.1371/journal.pone.0108233. eCollection 2014. IF(2012) = 3.73

350. Nejman-Faleńczyk B, Bloch S, Licznerska K, Felczykowska A, Dydecka A, Węgrzyn A, Węgrzyn G: Small regulatory RNAs in lambdoid bacteriophages and phage-derived plasmids: Not only antisense. Plasmid. 2014 Aug 8. pii: S0147-619X(14)00059-6. doi: 10.1016/j.plasmid.2014.07.006. IF(2013/2014) = 1.76

349. Cech GM, Pakuła B, Kamrowska D, Węgrzyn G, Arluison V, Szalewska-Pałasz A: Hfq protein deficiency in Escherichia coli affects ColE1-like but not λ plasmid DNA replication. Plasmid. 2014 May;73:10-5. doi: 10.1016/j.plasmid.2014.04.005. Epub 2014 May 5. IF(2013/2014) = 1.76

348. Moskot M, Montefusco S, Jakóbkiewicz-Banecka J, Mozolewski P, Węgrzyn A, Di Bernardo D, Węgrzyn G, Medina DL, Ballabio A, Gabig-Cimińska M: The phytoestrogen genistein modulates lysosomal metabolism and transcription factor EB (TFEB) activation. J Biol Chem. 2014 Jun 13;289(24):17054-69. doi: 10.1074/jbc.M114.555300. Epub 2014 Apr 25. IF(2013/2014) = 4.6

347. Zylicz-Stachula A, Bujnicki JM, Skowron PM: Correction: Cloning and analysis of a bifunctional methyltransferase/restriction endonuclease TspGWI, the prototype of a Thermus sp. enzyme family. BMC Mol Biol. 2014 Aug 5;15(1):16.  IF(2013/2014) = 2.057

346. Zylicz-Stachula A, Polska K, Skowron P, Rak J. Artificial plasmid labeled with 5-bromo-2'-deoxyuridine: a universal molecular system for strand break detection. Chembiochem. 2014 Jul 7;15(10):1409-12. doi: 10.1002/cbic.201402082. Epub 2014 May 21. IF(2013/2014) = 3.06

345. van der Ree MH, van der Meer AJ, de Bruijne J, Maan R, van Vliet A, Welzel TM, Zeuzem S, Lawitz EJ, Rodriguez-Torres M, Kupcova V, Wiercinska-Drapalo A, Hodges MR, Janssen HL, Reesink HW: Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients. Antiviral Res. 2014 Sep 8;111C:53-59. doi: 10.1016/j.antiviral.2014.08.015. IF(2013/2014) = 3.434

344. Hodnik Z, Loś JM, Zula A, Zidar N, Jakopin Z, Loś M, Sollner Dolenc M, Ilaš J, Węgrzyn G, Peterlin Mašič L, Kikelj D: Inhibition of biofilm formation by conformationally constrained indole-based analogues of the marine alkaloid oroidin. Bioorg Med Chem Lett. 2014 Apr 8. pii: S0960-894X(14)00330-8. doi: 10.1016/j.bmcl.2014.03.094. IF(2012) = 2.338

343. Gane EJ, Rouzier R, Wiercinska-Drapalo A, Larrey DG, Morcos PN, Brennan BJ, Le Pogam S, Nájera I, Petric R, Tran JQ, Kulkarni R, Zhang Y, Smith P, Yetzer ES, Shulman NS: Efficacy and Safety of Danoprevir-Ritonavir plus Peginterferon Alfa-2a-Ribavirin in Hepatitis C Virus Genotype 1 Prior Null Responders. Antimicrob Agents Chemother. 2014 Feb; 58(2):1136-45. doi: 10.1128/AAC.01515-13. IF(2012) = 4.565

342. Zylicz-Stachula A, Jezewska-Frackowiak J, Skowron PM: Cofactor analogue-induced chemical reactivation of endonuclease activity in a DNA cleavage/methylation deficient TspGWI N473A variant in the NPPY motif. Molecular Biology Reports 2014, DOI:10.1007/s11033-014-3085-x. IF(2012) = 2.506

341. Zylicz-Stachula A, Zolnierkiewicz O, Sliwinska K, Jezewska-Frackowiak J, Skowron PMModified 'one amino acid-one codon' engineering of high GC content TaqII-coding gene from thermophilic Thermus aquaticus results in radical expression increase. Microbial Cell Factories 2014, 13:7. DOI: 10.1186/1475-2859-13-7. IF(2012) = 3.31

340. Słomińska-Wojewódzka M, Pawlik A, Sokołowska I, Antoniewicz J, Węgrzyn G, Sandvig K: The role of EDEM2 compared with EDEM1 in ricin transport from the endoplasmic reticulum to the cytosol. Biochem J. 2014 Feb 1;457(3):485-96. IF(2012) = 4.654

339. Jakóbkiewicz-Banecka J, Gabig-Cimińska M, Banecka-Majkutewicz Z, Banecki B, Węgrzyn A, Węgrzyn G:  Factors and processes modulating phenotypes in neuronopathic lysosomal storage diseases. Metab Brain Dis. 2014 Mar;29(1):1-8.  IF(2012) = 2.333

338. Golec P, Karczewska-Golec J, Loś M, Węgrzyn G: Bacteriophage T4 can produce progeny virions in extremely slowly growing Escherichia coli host: comparison of a mathematical model with the experimental data. FEMS Microbiol Lett. 2014 Jan 4, doi: 10.1111/1574-6968.12372.  IF(2012) = 2.049

337. Nowicki D, Maciag-Dorszynska M, Kobiela W, Herman-Antosiewicz A, Wegrzyn A, Szalewska-Palasz A, Wegrzyn G: Phenethyl isothiocyanate inhibits Shiga toxin production in enterohemorrhagic Escherichia coli by the stringent response induction. Antimicrob Agents Chemother. 2014 Feb 3. IF(2012) = 4.565

336. Olszewski P, Szambowska A, Baranska S, Narajczyk M, Wegrzyn G, Glinkowska M: A dual promoter system regulating λ DNA replication initiation. Nucleic Acids Res. 2014 Feb 5. IF(2012) = 8.278

335. Maciąg-Dorszyńska M, Węgrzyn G, Guzow-Krzemińska B: Antibacterial activity of lichen secondary metabolite usnic acid is primarily caused by inhibition of RNA and DNA synthesis. FEMS Microbiol Lett. 2014 Feb 26. doi: 10.1111/1574-6968.12409. IF(2012) = 2.049

2013

334. Golec P, Karczewska-Golec J, Voigt B, Albrecht D, Schweder T, Hecker M, Wegrzyn G, Łos M: Proteomic profiles and kinetics of development of bacteriophage T4 and its rI and rIII mutants in slowly growing Escherichia coli. J Gen Virol. 2013 Apr;94(Pt 4):896-905. IF(2012) = 3.127

333. Wijburg FA, Węgrzyn G, Burton BK, Tylki-Szymańska A: Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder. Acta Paediatr. 2013 May;102(5):462-70. IF(2012) = 1.974

332. Barańska S, Glinkowska M, Herman-Antosiewicz A, Maciąg-Dorszyńska M, Nowicki D, Szalewska-Pałasz A, Węgrzyn A, Węgrzyn G: Replicating DNA by cell factories: roles of central carbon metabolism and transcription in the control of DNA replication in microbes, and implications for understanding this process in human cells. Microb Cell Fact. 2013 May 29;12:55. IF(2012) =  3.306

331. Bukowski M, Lyzen R, Helbin WM, Bonar E, Szalewska-Palasz A, Wegrzyn G, Dubin G, Dubin A, Wladyka B: A regulatory role for Staphylococcus aureus toxin-antitoxin system PemIKSa. Nat Commun. 2013;4:2012. IF(2012) = 10.015

330. Bloch S, Nejman-Faleńczyk B, Łoś JM, Barańska S, Łepek K, Felczykowska A, Łoś M, Węgrzyn G, Węgrzyn A: Genes from the exo-xis region of λ and Shiga toxin-converting bacteriophages influence lysogenization and prophage induction. Arch Microbiol. 2013 Nov;195(10-11):693-703.  IF(2012) = 1.905

329. Nowicki D, Kobiela W, Węgrzyn A, Wegrzyn G, Szalewska-Pałasz A: ppGpp-dependent negative control of DNA replication of Shiga toxin-converting bacteriophages in Escherichia coli. J Bacteriol. 2013 Nov;195(22):5007-15. IF(2012) = 3.194

328. Boss L, Labudda Ł, Węgrzyn G, Hayes F, Kędzierska B: The axe-txe complex of Enterococcus faecium presents a multilayered mode of toxin-antitoxin gene expression regulation. PLoS One. 2013 Sep 3;8(9):e73569. IF(2012) = 3.73

327. Połom D, Boss L, Węgrzyn G, Hayes F, Kędzierska B: Amino acid residues crucial for specificity of toxin-antitoxin interactions in the homologous Axe-Txe and YefM-YoeB complexes. FEBS J. 2013 Nov;280(22):5906-18. IF(2012) = 3.582

326. Pękala E, Liana P, Kubowicz P, Powroźnik B, Obniska J, Chlebek I, Węgrzyn A, Węgrzyn G: Evaluation of mutagenic and antimutagenic properties of new derivatives of pyrrolidine-2,5-dione with anti-epileptic activity, by use of the Vibrio harveyi mutagenicity test. Mutat Res. 2013 Dec 12;758(1-2):18-22. IF(2012) = 2.22

325. Orlikowska M, Szymańska A, Borek D, Otwinowski Z, Skowron PM, Jankowska E.: Structural characterizati on of V57D and V57P mutants of human cystatin C, an amyloidogenic protein. Acta Crystallogr D Biol Crystallogr. 2013, 69:577-86. IF(2012) = 14.1

324. Skowron PM, Vitkute J, Ramanauskaite D, Mitkaite G, Jezewska-Frackowiak J, Zebrowska J, Zylicz-Stachula A, Lubys, A: Three-stage biochemical selection: cloning of prototype class IIS/IIC/IIG restriction endonuclease-methyltransferase TsoI from the thermophile Thermus scotoductus. BMC Molecular Biology, 2013, 14:17. IF(2012) = 2.80

323. Zylicz-Stachula A, Zolnierkiewicz O, Jasiecki J, Skowron PM: A new genomic tool: ultra-frequently cleaving TaqII/sinefungin endonuclease with combined 2.9 bp recognition site, applied to the construction of horse DNA libraries. BMC Genomics 2013, 14:370. IF(2012) = 4.4

322. Janus Ł, Arasimowicz-Jelonek M, Milczarek G, Abramowski D, Floryszak-Wieczorek J: Normoergic NO-dependent changes, triggered by a SAR inducer in potato, create an augmented capacity for more potent defense responses to P. infestans. Plant Sci 2013, 211: 23-34. IF(2012) = 2.922 

321. Liberek A, Kmieć Z, Kartanowicz D, Wierzbicki PM, Stanisławowski M, Kaszubowska L, Łuczak G, Góra-Gębka M, Landowski P, Szlagatys-Sidorkiewicz A, Liberek T, Kamińska B, Jakóbkiewicz-Banecka J, Węgrzyn GThe mRNA level of the transforming growth factor 1 gene, but not the amount of the gene product, can be considered as a potential prognostic parameter in inflammatory bowel diseases in children. International Journal of Colorectal Disease, 2013 Feb;28(2):165-72. IF(2012) = 2.238

2012

320. Floryszak-Wieczorek J, Arasimowicz-Jelonek M, Milczarek G, Janus Ł, Pawlak-Sprada S, Abramowski D, Deckert J, Billert H: Nitric oxide-mediated stress imprint in potato as the effect of exposure to a priming agent. Mol. Plant Microbe Interact. 2012, 25:1469-77. IF(2012)  = 4.307 

319. Arasimowicz-Jelonek M, Kosmala A, Janus Ł, Abramowski D, Floryszak-Wieczorek J: The proteome response of potato leaves to priming agents and S-nitrosoglutathione. Plant Sci. 2012, 198:83-90. IF(2012)  = 2.922 

318. Żylicz-Stachula A, Żołnierkiewicz O, Lubys A, Ramanauskaite D, Mitkaite G, Bujnicki JM, Skowron PM: Related bifunctional restriction endonuclease-methyltransferase triplets: TspDTI, Tth111II/TthHB27I and TsoI with distinct specificities. BMC Molecular Biology 2012, 13:13. IF(2012) = 2.80 

317. Nejman-Faleńczyk B, Golec P, Maciąg M, Węgrzyn A, Węgrzyn G: Inhibition of development of Shiga toxin-converting bacteriophages by either treatment with citrate or amino acid starvation. Foodborne Pathogens and Disease 2012, 9:13-19. IF(2012) = 2.283

316. de Ruijter J, Valstar MJ, Narajczyk M, Węgrzyn G, Kulik W, Ijlst L, Wagemans T,  van der Wal WM, Wijburg FA: Genistein in Sanfilippo disease: a randomized controlled cross-over trial.  Annals of Neurology 2012,71:110-120. IF(2012) = 11.193

315. Malinová V, Węgrzyn G, Narajczyk M: The use of elevated doses of genistein-rich soy extract in the gene expression-targeted isoflavone therapy (GET IT) for Sanfilippo disease patients.  Journal of Inherited Metabolic Disease Reports 2012, 5:21-25. IF(2012) = 4.07

314. Korzon-Burakowska A, Jakóbkiewicz-Banecka J, Fiedosiuk A, Petrova N, Koblik T, Gabig-Cimińska M, Edmonds M, Małecki MT, Węgrzyn G: Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy. Diabetic Medicine 2012, 29:771–775. IF(2012) = 3.241

313. Jurecka A, Piotrowska E, Cimbalistiene L, Gusina N, Sobczyńska A, Czartoryska B, Czerska K, Õunap K, Węgrzyn G, Tylki-Szymańska A: Molecular analysis of mucopolysaccharidosis type VI in Poland, Belarus, Lithuania and Estonia. Molecular Genetics and Metabolism 2012, 105:237-243. IF(2012) = 2.834

312. Maciąg M, Nowicki D, Szalewska-Pałasz A, Węgrzyn G: Central carbon metabolism influences fidelity of DNA replication in Escherichia coli. Mutation Research 2012, 731:99-106. IF(2012) = 3.902

311. Węgrzyn G, Licznerska K, Węgrzyn A: Phage – new insights into regulatory circuits.  Advances in Virus Research 2012, 82:155-178. IF(2012) = 2.844

310. Łoś M, Węgrzyn G: Pseudolysogeny. Advances in Virus Research 2012, 82:339-349. IF(2012) = 2.844

309. Kluk A, Łoś M, Węgrzyn G: An improved method for efficient isolation and purification of genomic DNA from filamentous cyanobacteria belonging to genera Anabaena, Nodularia and Nostoc. Oceanological and Hydrobiological Studies 2012, przyjęta do druku. IF(2012) = 0.400

308. Maciąg-Dorszyńska M, Ignatowska M, Janniere L, Węgrzyn G, Szalewska-Pałasz A: Mutations in central carbon metabolism genes suppress defects in nucleoid position and cell division of replication mutants in Escherichia coli. Gene 2012,503:31-35 IF(2012) = 2.196

307. Narajczyk M, Tylki-Szymańska A, Węgrzyn G: Changes in hair morphology as a biomarker in gene expression-targeted isoflavone therapy for Sanfilippo disease. Gene 2012,504:292-295 IF(2012) = 2.196

306. Banecka-Majkutewicz Z, Jakóbkiewicz-Banecka J, Gabig-Cimińska M, Węgrzyn A, Węgrzyn G: Putative biological mechanisms of efficiency of substrate reduction therapies for mucopolysaccharidoses. Archivum Immunologiae et Therapiae Experimentalis 2012, 60(6):461-8. IF(2012) = 2.378

305. Kloska A, Narajczyk M, Jakóbkiewicz-Banecka J, Grynkiewicz G, Szeja W, Gabig-Cimińska M, Węgrzyn G: Synthetic genistein derivatives as modulators of glycosaminoglycan storage. Journal of Translational Medicine 2012,10:153. IF(2012) = 3.459

304. Golec P, Karczewska-Golec J, Łoś M, Węgrzyn G: Novel ZnO-binding peptides obtained by the screening of a phage display peptide library. Journal of Nanoparticle Research 2012, 14:1218. IF(2012) = 2.175

303. Moskot M, Kotlarska E, Jakóbkiewicz-Banecka J, Gabig-Cimińska M, Fari K, Węgrzyn G, Wróbel B: Metal and antibiotic resistance of bacteria isolated from the Baltic Sea. International Microbiology  2012, 15:131-139. IF(2012) = 2.556

302. Jurecka A, Żuber Z, Opoka-Winiarska V, Węgrzyn G, Tylki-Szymańska A: Effect of rapid cessation of enzyme replacement therapy: a report of 5 cases and a review of the literature. Molecular Genetics and Metabolism 2012, 107:508-512. IF(2012) = 2.834

2011

301. Żylicz-Stachula A, Żołnierkiewicz O, Śliwińska K, Jeżewska-Frąckowiak J, Skowron PM:Bifunctional TaqII restriction endonuclease: redefining the prototype DNA recognition site and establishing the Fidelity Index for partial cleaving. BMC Biochemistry 2011, 12:62. IF(2012) = 1.78

300. Orlikowska M, Jankowska E, Borek D, Otwinowski Z, Skowron P, Szymanska A: Crystallization and preliminary X-ray diffraction analysis of V57 mutants of an amyloidogenic protein – human cystatin C. Acta Crystallographica Section F 2011, F67:1608-1611. IF(2012) = 0.55

299. Żylicz-Stachula A, Żołnierkiewicz O, Jeżewska-Frąckowiak J, Skowron PM: Chemically-induced affinity star restriction specificity: a novel TspGWI/sinefungin endonuclease with theoretical 3-bp cleavage frequency. BioTechniques  2011, 50:397-406. IF(2012) = 2.4

298. Sobolewski I, Polska K, Żylicz-Stachula A, Jeżewska-Frąckowiak J, Rak J, Skowron PM:Enzymatic synthesis of long double-stranded DNA labeled with the haloderivatives of nucleobases in a precisely pre-determined sequence. BMC Biochemistry 2011, 12:24. IF(2012) = 1.78

297. Michalska B, Sobolewski I, Polska K, Zielonka J, Żylicz-Stachula A, Skowron PM, Rak J: PCR synthesis of double stranded DNA labeled with 5-bromouridine. A step towards finding a bromonucleoside for clinical trials. Journal of Pharmaceutical and Biomedical Analysis 2011, 56:671-677. IF(2012) = 2.95

296. Kloska A, Jakóbkiewicz-Banecka J, Tylki-Szymańska A, Czartoryska B, Węgrzyn G: Female Hunter syndrome caused by a single mutation and familial XCI skewing: implications for other X-linked disorders. Clinical Genetics 2011,80:459-465. IF(2012) = 3.944

295. Wenne R, Handschuh L, Poćwierz-Kotus A, Urbaniak R, Formanowicz P, Całkiewicz J, Brzozowska K, Figlerowicz M, Węgrzyn G, Wróbel B: The application of microarray technology to the identification of Tc1-like element sequences in fish genomes. Marine Biology Research 2011,7:466-477. IF(2012) = 0.962

294. Pronicka E, Węglewska-Jurkiewicz A, Pronicki M, Sykut-Cegielska J, Kowalski P, Pajdowska M, Jankowska I, Kotulska K, Kaliciński P, Jakóbkiewicz-Banecka J, Węgrzyn G: Drug-resistant epilepsia and fulminant valproate liver toxicity: Alpers-Huttenlocher syndrome in two children confirmed post mortem by identification of p.W748S mutation in POLG gene. Medical Science Monitor 2011, 17:CR203-209. IF(2012) = 1.358

293. Golec P, Wiczk A, Łoś JM, Konopa G, Węgrzyn G, Łoś M: Persistence of bacteriophage T4 in a starved Escherichia coli culture: evidence for the presence of phage subpopulations. Journal of General Virology 2011, 92:997-1003. IF(2012) = 3.127

292. Golec P, Dąbrowski K, Hejnowicz M, Gozdek A, Łoś JM, Węgrzyn G, Łobocka M, Łoś M: A reliable method for storage of tailed phages. Journal of Microbiological Methods 2011, 84:486-489. IF(2012) = 2.161

291. Kloska A, Jakóbkiewicz-Banecka J, Narajczyk M, Banecka-Majkutewicz Z, Węgrzyn G: Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses. Metabolic Brain Disease 2011, 26, 1-8. IF(2012) = 2.333

290. Szambowska A, Pierechod M, Węgrzyn G, Glinkowska M: Coupling of transcription and replication machineries in the λ DNA replication initiation: evidence for direct interaction of Escherichia coli RNA polymerase and the O protein. Nucleic Acids Research 2011,39:168-177. IF(2012) = 8.278

289. Nejman B, Nadratowska-Wesołowska B, Szalewska-Pałasz A, Węgrzyn A, Węgrzyn G: Replication of plasmids derived from Shiga toxin-converting bacteriophages in starved Esherichia coli. Microbiology 2011, 157:220-233. IF(2012) = 2.852

288. Klawitter E, Kunikowska D, Tokarska-Pietrzak E, Dziadziuszko H, Łoś JM, Golec P, Węgrzyn G, Łoś M: Specific detection of Salmonella enterica and Escherichia coli strains by using ELISA with bacteriophages as recognition agents. European Journal of Clinical Microbiology and Infectious Diseases 2011, 30:1067-1073. IF(2012) = 3.024

287. Pronicka E, Węglewska-Jurkiewicz A, Taybert J, Pronicki M, Szymańska-Dębińska T, Karkucińska-Więckowska A, Jakóbkiewicz-Banecka J, Kowalski P, Piekutowska-Abramczuk D, Pajdowska M, Socha P, Sykut-Cegielska J, Węgrzyn G: Post mortem identification of deoxyguanosine kinase gene (DGUOK) mutations combined with impaired glucose hoeostasis and iron overload features in four infants with severe progressive liver failure. Journal of Applied Genetics 2011, 52:61-66. IF(2012) = 1.847

286. Piotrowska E, Jakóbkiewicz-Banecka J, Maryniak A, Tylki-Szymańska A, Puk E, Liberek A, Węgrzyn A, Czartoryska B, Słomińska-Wojewódzka M, Węgrzyn G: Two years follow-up of Sanfilippo disease patients treated with a genistein-rich isoflavone extract: assessment of effects on cognitive functions and general status of patients. Medical Science Monitor 2011, 17:CR196-202. IF(2012) = 1.358

285. Jurecka A, Rozdzynska A, Marucha J, Czartoryska B, Węgrzyn G, Tylki-Szymańska A: Natural history of Polish patients with mucopolysaccharidosis type VI. Central European Journal of Medicine 2011, 6:163-171. IF(2012) = 0.262

284. Sokołowska I, Wälchli S, Węgrzyn G, Sandvig K, Słomińska–Wojewódzka M: A single point mutation in ricin A-chain increases toxin degradation and inhibits EDEM1-dependent ER retrotranslocation. Biochemical Journal 2011, 436:371-385. IF(2012) = 4.654

283. Maciąg M, Nowicki D, Janniere L, Szalewska-Pałasz A, Węgrzyn G: Genetic response to metabolic fluctuations: correlation between central carbon metabolism and DNA replication in Escherichia coli. Microbial Cell Factories 2011, 10:19.  IF(2012)  = 3.306

282. Marucha J, Tylki-Szymańska A, Jakóbkiewicz-Banecka J, Piotrowska E, Kloska A, Czartoryska B, Węgrzyn G: Improvement in the range of joint motion in seven patients with mucopolysaccharidosis type II during experimental gene expression-targeted isoflavone therapy (GET IT). American Journal of Medical Genetics A 2011, 155:2257-2262. IF(2012) = 2.304

281. Langford-Smith A, Malinowska M, Langford-Smith K, Wegrzyn G, Jones S, Wynn R, Wraith JE, Wilkinson F, Bigger B: Hyperactive behaviour in the mouse model of Mucopolysaccharidosis IIIB in the open field and home cage environments. Genes, Brain and Behavior 2011, 10:673-682. IF(2012) = 3.597

21. Łoś JM, Łoś M, Węgrzyn G: Bacteriophages carrying Shiga toxin genes: genomic variations, detection and potential treatment of pathogenic bacteria. Future Microbiology 2011, 6:909-924. IF(2012) = 4.018

280. Jakóbkiewicz-Banecka J, Piotrowska E, Gabig-Cimińska M, Borysiewicz E, Słomińska-Wojewódzka M, Narajczyk M, Węgrzyn A, Węgrzyn G: Substrate reduction therapies for mucopolysaccharidoses. Current Pharmaceutical Biotechnology 2011, 12:1860-1865. IF(2012) = 2.690

279. Dmochowska B, Piosik J, Woziwodzka A, Sikora K, Wiśniewski A, Węgrzyn G: Mutagenicity of quaternary ammonium salts containing carbohydrate moieties. Journal of Hazardous Materials 2011,193:272-278. IF(2012) = 3.925

278. Łoś JM, Węgrzyn G: Enterokrwotoczne szczepy Escherichia coli (EHEC) i bakteriofagi kodujące toksyny Shiga. Postępy Mikrobiologii 2011, 50:175-190. IF(2012) = 0.207

277. Liberek A, Jakóbkiewicz-Banecka J, Kloska A, Świderska J, Kmieć Z,  Łuczak G, Wierzbicki P,  Liberek T, Marek K, Plata-Nazar K,  Sikorska-Wiśniewska G, Kamińska B, Węgrzyn G: Clinical parameters of inflammatory bowel disease in children do not correlate with four common polymorphisms of the transforming growth factor 1 gene. Acta Biochimica Polonica 2011, 58:641-644. IF(2012) = 1.185

276. Chlabicz S, FlisiakR, Łapiński TW, Kowalczuk O, Wiercińska-Drapało A, Pytel-Krolczuk, Grzeszczuk, Chyczewski, Pancewicz S: Epidemiological features of patients infected with HCV genotype 4 in Poland – a cross-sectional study. Hepatitis Monthly 2011. IF(2012) = 1.245

2010

275. Polska K, Zielonka J, Chomicz L, Czerwicka M, Stepnowski P, Guzow K, Wiczk W, Smużyńska M, Kasprzykowski F, Żylicz-Stachula A, Skowron PM, Rak J: Unexpected photoproduct generated via the acetone- sensitized photolysis of 5-Bromo-2’-deoxyuridine in a water/isopropanol solution: experimental and computational studies. Journal of Physical Chemistry B 2010, 114: 16902-16907. IF(2012) = 3.607

274. Słoczyńska K, Pękala E, Wajda A, Węgrzyn G, Marona H: Evaluation of mutagenie and antimutagenic properties of some bioactive xanthone derivatives using Vibrio harveyi test. Letters in Applied Microbiology 2010, 50:252-257. IF(2012) = 1.629

273. Maciąg M, Kochanowska M, Łyżeń R, Węgrzyn G, Szalewska-Pałasz A: ppGpp inhibits the activity of Escherichia coli DnaG primase. Plasmid 2010, 63:61-67. IF(2012) = 1.276

272. Piotrowska E, Jakóbkiewicz-Banecka J, Węgrzyn G: Different amounts of isoflavones in various commercially available soy extracts in the light of gene expression-targeted isoflavone therapy. Phytotherapy Research 2010,24:S109-S113. IF(2012) = 2.068

271. Dziedzic D, Węgrzyn G, Jakóbkiewicz-Banecka J: Impairment of glycosaminoglycan synthesis in mucopolysaccharidosis type IIIA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease. European Journal of Human Genetics 2010, 18:200-205. IF(2012) = 4.319

270. Łoś JM,  Łoś M, Węgrzyn A, Węgrzyn G: Hydrogen peroxide-mediated induction of the Shiga toxin-converting lambdoid prophage ST2-8624 in Escherichia coli O157:H7. FEMS Immunology and Medical Microbiology 2010, 58:322-329. IF(2012) = 2.684

269. Węgrzyn G, Jakóbkiewicz-Banecka J, Gabig-Cimińska M, Piotrowska E, Narajczyk M, Kloska A, Malinowska M, Dziedzic D, Gołębiewska I, Moskot M,  Węgrzyn A: Genistein: a natural isoflavone with a potential for treatment of genetic diseases. Biochemical Society Transactions 2010, 38:695-701. IF(2012) = 2.587

268. Glinkowska M, Łoś JM, Szambowska A, Czyż A, Całkiewicz J, Herman-Antosiewicz A, Wróbel B, Węgrzyn G, Węgrzyn A, Łoś M: Influence of the Escherichia coli oxyR gene function onprophage maintenance. Archives of Microbiology 2010, 192:673-683. IF(2012) = 1.905

267. Nadratowska-Wesołowska B, Słomińska-Wojewódzka M, Łyżeń R, Węgrzyn A, Szalewska-Pałasz A, Węgrzyn G: Transcription regulation of the Escherichia coli pcnB gene coding for poly(A) polymerase I: roles of ppGpp, DksA and sigma factors. Molecular Genetics and Genomics 2010, 284:289-305.  IF(2012) = 2.881

266. Węgrzyn G, Jakóbkiewicz-Banecka J, Narajczyk M, Wiśniewski A, Piotrowska E, Gabig-Cimińska M, Kloska A, Słomińska-Wojewódzka M, Korzon-Burakowska A, Węgrzyn A: Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different? Medical Hypotheses 2010, 75:605-609. IF(2012) = 1.054

265. Golec P, Wiczk A, Majchrzyk A, Łoś JM, Węgrzyn G, Łoś M: A role for accessory genes rI.-1 and rI.1 in the regulation of lysis inhibition (LIN) by bacteriophage T4. Virus Genes 2010,41:459-468. IF(2012) = 1.769

264. Mikuła T, Kozłowska J, Wiercińska-Drapało A: Pulmonary rhodococcosis (Rhodococcus equi) imitating Pancoast tumour in an HIV-infected patient. Reviews in Medical Microbiology 2010, 21:65–67 IF(2012) = 0.355

263. Stefaniuk P, Cianciara J, Wiercinska-Drapalo A:Present and future possibilities for early diagnosis of hepatocellular carcinoma. World J Gastroenterol 2010 Jan 28, 16(4):418-24 IF(2012) = 2.547

262. Mocroft A, Phillips AN, Ledergerber B, Smith C, Bogner JR, Lacombe K, Wiercinska-Drapalo A, Reiss P, Kirk O, Lundgren JD, EuroSIDA Study Group: Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapy. Antivir Ther 2010, 15(4):563-70. IF(2012) =3.073

261. Stańczak GP, Stańczak JJ, Marczyńska M, Firlag-Burkacka E, Wiercińska-Drapało A, Leszczyszyn-Pynka M, Jabłonowska E, Małolepsza E, Dyda T, Zabek P, Horban A: Evolving patterns of HIV-1 transmitted drug resistance in Poland in the years 2000-2008. J Med Virol 2010 Jul, 82(7):1291-4. IF(2012) = 2.373

260. Reekie J, Kosa C, Engsig F, Monforte A, Wiercinska-Drapalo A, Domingo P, Antunes F, Clumeck N, Kirk O, Lundgren JD, Mocroft A, EuroSIDA Study Group: Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies.Cancer 2010 Nov 15, 116(22):5306-15. IF(2012) = 5.201

2009

259. Żylicz-Stachula A, Bujnicki JM, Skowron PM: Cloning and analysis of bifunctional DNA methyltransferase/nuclease TspGWI, the prototype of a Thermus sp. family. BMC Molecular Biology 2009, 10:52. IF(2012) = 2.80

258. Piotrowska E, Jakóbkiewicz-Banecka J, Tylki-Szymańska A, Czartoryska B, Węgrzyn A, Węgrzyn G: Correlation between severity of mucopolysaccharidoses and combination of the residual enzyme activity and efficiency of glycosaminoglycan synthesis. Acta Paediatrica 2009, 98:743–749. IF(2012) = 1.974

257. Wang Z, Jin L, Yuan Z, Węgrzyn G, Węgrzyn A: Classification of plasmid vectors using replication origin, selection marker and promoter as criteria. Plasmid 2009, 61:47-51. IF(2012) = 1.276

256. Królicka A, Szpitter A, Maciąg M, Biskup E, Gilgenast E, Romanik G, Kamiński M, Węgrzyn G, Łojkowska E: Antibacterial and antioxidant activity of the secondary metabolites from in vitro cultures of Drosera alicie. Biotechnology and Applied Biochemistry 2009, 53:175-184. IF(2012) = 1.348

255. Sawuła W, Banecka-Majkutewicz Z, Kadziński L, Jakóbkiewicz-Banecka J, Węgrzyn G, Nyka W, Banecki B: Homocysteine level and metabolism in ischemic stroke in the population of Northern Poland. Clinical Biochemistry 2009, 42:442-447. IF(2012) = 2.45

254. Jakóbkiewicz-Banecka J, Piotrowska E, Narajczyk M, Barańska S, Węgrzyn G: Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway.  Journal of Biomedical Science 2009, 16:26. IF(2012) = 2.45

253. Wang Z, Jin L, Węgrzyn G, Węgrzyn A: A novel method for screening the glutathione transferase inhibitors. BMC Biochemistry 2009, 10:6. IF(2012) = 1.776

252 Mazur-Marzec H, Toruńska A, Błońska MJ, Moskot M, Pliński M, Jakóbkiewicz-Banecka J, Węgrzyn G: Biodegradation of nodularin and effects of the toxin on bacterial isolates from the Gulf of Gdańsk. Water Research 2009, 43:2801-2810. IF(2012) = 4.655

251. Malinowska M, Wilkinson FL, Bennett W, Langford-Smith KJ, O’Leary HA, Jakóbkiewicz-Banecka J, Wynn R, Wraith JE, Węgrzyn G, Bigger BW: Genistein reduces lysosomal storage in peripheral tissues of Mucopolysaccharide IIIB mice. Molecular Genetics and Metabolism 2009, 98:235-242. IF(2012) = 2.834

250. Nejman B, Łoś JM, Łoś M, Węgrzyn G, Węgrzyn A: Plasmids derived from lambdoid bacteriophages as models for studying replication of mobile genetic elements responsible for production of Shiga toxins by pathogenic Escherichia coli strains. Journal of Molecular Microbiology and Biotechnology 2009, 17:211-220. IF(2012) = 1.679

249. Łyżeń R, Kochanowska M, Węgrzyn G, Szalewska-Pałasz A: Transcription from bacteriophage pR promoter is regulated independently and antagonistically by DksA and ppGpp. Nucleic Acids Research 2009, 37:6655-6664. IF(2012) = 8.278

248. Łoś JM, Łoś M, Węgrzyn G, Węgrzyn A: Differential efficiency of induction of various lambdoid prophages responsible for production of Shiga toxins in response to different induction agents. Microbial Pathogenesis 2009, 47:289-298. IF(2012) = 1.974

247. Plata K, Rosato AE, Węgrzyn G: Staphylococcus aureus as an infectious agent: overview of biochemistry and molecular genetics of its pathogenicity. Acta Biochimica Polonica 2009, 56:597-612. IF(2012) = 1.185

2008

246. Kurlenda J, Grinholc M, Węgrzyn G: Presence of cna, emp and pls genes and pathogenicity of methicillin-resistant Staphylococcus aureus strains. World Journal of Microbiology and Biotechnology 2008, 24:591-594. IF(2012) = 1.262

245. Łoś M, Łoś JM, Węgrzyn G: Rapid identification of Shiga toxin-producing Escherichia coli (STEC) using electric biochips.  Diagnostic Molecular Pathology  2008, 17:179-184. IF(2012) = 1.861

244. Podgórska B, Królicka A, Łojkowska E, Węgrzyn G: Rapid detection of mutagens accumulated in plant tissues using a novel Vibrio harveyi mutagenicity assay. Ecotoxicology and Environmental Safety 2008, 70:231-235. IF(2012) = 2.203

243. Chęć E, Podgórska B, Węgrzyn G: Comparison of the use of mussels and semipermeable membrane devices for monitoring and assessment of accumulation of mutagenic pollutants in marine environment in combination with a novel microbiological mutagenicity assay. Environmental Monitoring and Assessment 2008, 140:83-90. IF(2012) = 1.592

242. Wang Z, Jin L, Węgrzyn G, Węgrzyn A: Screening of the osmotic pressure-inducible promoter regions from the whole genome of Escherichia coli by using a novel cloning method. Biotechnology Letters 2008, 30:707-711. IF(2012) = 1.853

241. Malinowska M, Jakóbkiewicz-Banecka J, Kloska A, Tylki-Szymańska A, Czartoryska B, Piotrowska E, Węgrzyn A, Węgrzyn G: Abnormalities in the hair morphology of patients with some but not all types of mucopolysaccharidoses. European Journal of Pediatrics 2008, 167:203-209. IF(2012) = 1.907

240. Węgrzyn G, Węgrzyn A: Is tRNA only a translation factor or also a regulator for other processes? Journal of Applied Genetics 2008, 49:115-122. IF(2012) = 1.847

239. Sawuła W, Banecka-Majkutewicz Z, Kadziński L, Jakóbkiewicz-Banecka J, Węgrzyn G, Nyka W, Banecki B: Improved HPLC method for total plasma homocysteine detection and quantification. Acta Biochimica Polonica 2008, 55:119-125. IF(2012) = 1.185

238. Piotrowska E, Jakóbkiewicz-Banecka J, Tylki-Szymańska A, Liberek A, Maryniak A, Malinowska M, Czartoryska B, Puk E, Kloska A, Liberek T, Barańska S, Węgrzyn A, Węgrzyn G: Genistin-rich isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: an open-label, pilot study in 10 pediatric patients. Current Therapeutic Research Clinical and Experimental 2008, 69:166-179. IF(2012) = 0.446

237. Łyżeń R, Kochanowska M, Węgrzyn G, Szalewska-Pałasz A: IHF- and SeqA-binding sites, present in plasmid cloning vectors, may significantly influence activities of promoters. Plasmid 2008, 60:125-130. IF(2012) = 1.276

236. Łoś JM, Golec P, Węgrzyn G, Węgrzyn A, Łoś M: Simple method for plating Escherichia coli bacteriophages forming very small plaques or no plaques under standard conditions. Applied and Environmental Microbiology 2008, 74:5113-5120. IF(2012) = 3.678

235. Łoś JM, Łoś M, Węgrzyn A, Węgrzyn G: Role of the bacteriophageexo-xis region in the virus development. Folia Microbiologica 2008, 53:443-450. IF(2012) = 0.791

234. Basselet P, Węgrzyn G, Enfors S-O, Gabig-Cimińska M: Sample processing for DNA chip array-based analysis of enterohemorrhagic Escherichia coli (EHEC). Microbial Cell Factories 2008, 7:29. IF(2012) = 3.306

233. De Felice M, Mattanovich D, Papagianni M, Wegrzyn G, Villaverde A: The scientific impact of microbial cell factories. Microbial Cell Factories 2008, 7:33. IF(2012) = 3.306

232. Cozzi-Lepri A, Phillips AN, Clotet B, Mocroft A, Ruiz L, Kirk O, Lazzarin A, Wiercinska-Drapalo A, Karlsson A, Lundgren JD: EuroSIDA Study Group Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study. AIDS 2008, 22(16):2187-98. IF(2012) = 6.407

231. Flisiak R, Horban A, Gallay P, Bobardt M, Selvarajah S, Wiercinska-Drapalo A, Siwak E, Cielniak I, Higersberger J, Kierkus J, Aeschlimann C, Grosgurin P, Nicolas-Métral V, Dumont JM, Porchet H, Crabbé R, Scalfaro P: The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus. Hepatology 2008, 47(3):817-26. IF(2012) = 12.003

230. Chlabicz S, Flisiak R, Kowalczuk O, Wiercińska-Drapalo A, Pytel-Krolczuk B, Prokopowicz D, Chyczewski L: High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland. J Med Virol 2008, 80(4):615-8. IF(2012) = 2.373

2007

229. Wang Z, Xiang L, Shao J, Węgrzyn G: Adenosine monophosphate-induced amplification of ColE1 plasmid DNA in Escherichia coli. Plasmid  2007, 57:265-274. IF(2012) = 1.276

228. Łoś M, Węgrzyn G: Electric bio-chips for rapid and quantitative detection of specific biological materials. Current Nanoscience 2007, 3:129-133. IF(2012) = 1.356

227. Podgórska B, Pazdro K, Pempkowiak J, Węgrzyn G: The use of a novel Vibrio harveyi luminescence mutagenicity assay in testing marine water for the presence of mutagenic pollution. Marine Pollution Bulletin 2007, 54:808-814.  IF(2012) = 2.531

226. Węglewska-Jurkiewicz A, Jakóbkiewicz-Banecka J, Pronicka E, Węgrzyn G: False positive results of mitochondrial DNA depletion/deletion due to single nucleotide substitutions causing appearance of additional PvuII restriction sites. Diagnostic Molecular Pathology 2007, 16:116-120. IF(2012) = 1.861

225. Narajczyk M, Barańska S, Szambowska A, Glinkowska M, Węgrzyn A, Węgrzyn G: Modulation of plasmid and phage DNA replication by Escherichia coli SeqA protein.Microbiology2007, 153:1653-1663. IF(2012) = 2.852

224. Kurlenda J, Grinholc M, Jasek K, Węgrzyn G: RAPD typing of methycillin-resistant Staphylococcus aureus: a 7-year experience in a Polish hospital. Medical Science Monitor 2007, 13, MT13-MT18. IF(2012) = 1.358

223. Słomiński B, Całkiewicz J, Golec P, Węgrzyn G, Wróbel B: Plasmids derived from Gifsy-1/Gifsy-2, lambdoid prophages contributing to the virulence of Salmonella enterica serovar Typhimurium: implications for the evolution of replication initiation proteins of lambdoid phages and enterobacteria. Microbiology 2007, 153:1884-1896. IF(2012) = 2.852

222. Ulanowska K, Majchrzyk A, Moskot M, Jakóbkiewicz-Banecka J, Węgrzyn G: Assessment of antibacterial effects of flavonoids by estimation of generation times in liquid bacterial cultures. Biologia 2007, 62:132-135. IF(2012) = 0.506

221. Łoś M, Golec P, Łoś JM, Węglewska-Jurkiewicz A, Czyż A, Węgrzyn A, Węgrzyn G, Neubauer P: Effective inhibition of lytic development of bacteriophages, P1 and T4 by starvation of their host, Escherichia coli. BMC Biotechnology 2007, 7:13. IF(2012) = 2.165

220. Narajczyk M, Barańska S, Węgrzyn A, Węgrzyn G: Switch fromtoreplication of bacteriophageDNA: factors involved in the process and a model for its regulation. Molecular Genetics and Genomics 2007, 278:65-74.  IF(2012) = 2.881

219. Kędzierska B, Szambowska A, Herman-Antosiewicz A, Lee DJ, Busby SJW, Węgrzyn G, Thomas MS: The C-terminal domain of the Escherichia coli RNA polymerasesubunit plays a role in the CI-dependent activation of the bacteriophagepM promoter. Nucleic Acids Research 2007, 35:2311-2320. IF(2012) = 8.278

218. Węgrzyn G, Tylki-Szymańska A, Liberek A,  Piotrowska E, Jakóbkiewicz-Banecka J, Marucha J, Czartoryska B, Węgrzyn A: Rapid deterioration of a patient with mucopolysaccharidosis type I during interruption of enzyme replacement therapy. American Journal of Medical Genetics 2007, 143A:1925-1927. IF(2012) = 2.304

217. Grinholc M, Węgrzyn G, Kurlenda J: Evaluation of biofilm production and prevalence of the icaD gene in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains isolated from patients with nosocomial infections and carriers. FEMS Immunology and Medical Microbiology 2007, 50:375-379. IF(2012) = 2.684

216. Ulanowska K, Piosik J, Gwizdek-Wiśniewska A, Węgrzyn G: Impaired mutagenic activities of MPDP+ (1-methyl-4-phenyl-2,3-dihydropyridinium) and MPP+ (1-methyl-4-phenylpyridinium) due to their interactions with methylxanthines. Bioorganic and Medicinal Chemistry 2007, 15:5150-5157. IF(2012) = 2.903

215. Szalewska-Pałasz A, Węgrzyn G, Węgrzyn A: Mechanisms of physiological regulation of RNA synthesis in bacteria: new discoveries breaking old schemes. Journal of Applied Genetics 2007, 48, 281-294. IF(2012) = 1.847

214. Podgórska B, Pazdro K, Węgrzyn G: The use of the Vibrio harveyi luminescence mutagenicity assay as a rapid test for preliminary assessment of mutagenic pollution of marine sediments.  Journal of Applied Genetics 2007, 48:409-412. IF(2012) =1.847

213. Jakóbkiewicz-Banecka J, Węgrzyn A, Węgrzyn G: Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases. Journal of Applied Genetics 2007, 48:383-388. IF(2012) = 1.847

212. Podgórska B, Węgrzyn G: The use of marine bacteria in mutagenicity assays. Polish Journal of Microbiology 2007, 56:227-231. IF(2012) = 0.768

211. Wiercinska-Drapalo A,Jaroszewicz J, Tarasow E, Siergiejczyk L, Prokopowicz D: The possible association between serum cholesterol concentration and decreased bone mineral density as well as intravertebral marrow fat in HIV-1 infected patients. Infection 2007, 35(1):46-8. IF(2012) = 2.440

210. Choromańska M, Waszkiel D, Klimiuk A, Wiercińska-Drapało A, Ruczaj J:The frequency of oral cavity candidiasis occurrence in HIV infected subjects according to undertaking HAART.Polish Journal of Environmental Studies 2007, 16(2):501-504. IF(2012) = 0.462

209. Choromańska M, Waszkiel D, Klimiuk A, Wiercińska-Drapało A, Ruczaj J: The impact of HAART therapy on periodontal status in HIV infected persons. Polish Journal of Environmental Studies 2007,16(2):209-212. IF(2012) = 0.462

208. Łapinski TW, Wiercińska-Drapało A, Panasiuk A, Kovalchuk O: Concentrations of ssDNA in liver tissue and its correlation with sFas and sFasL in serum of patients infected with HBV, HCV, HCV and HIV. Adv Med Sci 2007, 52:109-13 IF(2012) = 0.796

2006

207. Jasiecki J, Węgrzyn G: Transcription start sites in the promoter region of the Escherichia coli pcnB (plasmid copy number) gene coding for poly(A) polymerase I. Plasmid 2006, 55:169-172. IF(2012) = 1.276

206. Ulanowska K, Tkaczyk A, Konopa G, Węgrzyn G: Differential antibacterial activity of genistein arising from global inhibition of DNA, RNA and protein synthesis in some bacterial strains.  Archives of Microbiology 2006, 184:271-278. IF(2012) = 1.905

205. Ulanowska K, Węgrzyn G: Mutagenic activity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Journal of Applied Genetics 2006, 47:85-87. IF(2012) = 1.847

204. Podgórska B, Węgrzyn G: A modified Vibrio harveyi mutagenicity assay based on bioluminescence induction. Letters in Applied Microbiology 2006, 42:578-582. IF(2012) = 1.629

203. Sikora AE, Zielke R, Węgrzyn A, Węgrzyn G: DNA replication defect in the Escherichia coli cgtA(ts) mutant arising from reduced DnaA levels. Archives of Microbiology 2006, 185:340-347. IF(2012) = 1.905

202. Piotrowska E, Jakóbkiewicz-Banecka J, Barańska S, Tylki-Szymańska A, Czartoryska B, Węgrzyn A, Węgrzyn G: Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses. European Journal of Human Genetics 2006, 14:846–852. IF(2012) = 4.319

201. Hinc K, Nagórska K, Iwanicki A, Węgrzyn G, Seror SJ, Obuchowski M: Expression of genes coding for GerA and GerK spore germination receptors is dependent on the protein phosphatase PrpE. Journal of Bacteriology 2006, 188:4373-4383. IF(2012) = 3.194

200. Jasiecki J, Węgrzyn G: Phosphorylation of Escherichia coli poly(A) polymerase I and effects of this modification on the enzyme activity. FEMS Microbiology Letters 2006, 261:118-122. IF(2012)  = 2.049

199. Wysocka A, Konopa G, Węgrzyn G, Wróbel B: Genomic DNA hybridization as an attempt to evaluate phylogenetic relationships of Ostracoda. Crustaceana 2006, 79:1309-1322. IF(2012) =  0.466

198. Chęć E, Podgórska B, Węgrzyn G: Direct addition of cultures of tester bacteria into semipermeable membrane devices (SPMDs) as a modified procedure for preliminary detection of mutagenic pollution of marine environment using microbiological mutagenicity assays. Mutation Research 2006, 611:17-24. IF(2012) = 2.22

197. Łyżeń R, Węgrzyn G, Węgrzyn A, Szalewska-Pałasz A: Stimulation of the pR promoter by Escherichia coli SeqA protein requires downstream GATC sequences and involves late stages of transcription initiation. Microbiology 2006, 152:2985-2992. IF(2012) = 2.852

196. Wang Z, Yuan Z, Xiang L, Shao J, Węgrzyn G: tRNA-dependent cleavage of the ColE1 plasmid-encoded RNA I. Microbiology 2006, 152:3467-3476. IF(2012) = 2.852

195. Wang Z, Xiang L, Shao J, Węgrzyn A, Węgrzyn G: Effects of the presence of ColE1 plasmid DNA in Escherichia coli on the host cell metabolism. Microbial Cell Factories 2006, 5:34. IF(2012) = 3.306

194. Lapinski TW, Jaroszewicz J, Wiercinska-Drapalo A: Concentrations of soluble Fas and soluble Fas ligand as indicators of programmed cell death among patients coinfected with Human Immunodeficiency Virus and Hepatitis C Virus. Viral Immunol 2006, 19(3):570-5. IF(2012) = 1.75

193. Jaroszewicz J, Wiercinska-Drapalo A, Lapinski TW, Prokopowicz D, Rogalska M, Parfieniuk A: Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration. Antivir Ther 2006, 11(5):641-5. IF(2012) = 3.073

192. Podlasin RB, Wiercinska-Drapalo A, Olczak A, Beniowski M, Smiatacz T, Malolepsza E, Juszczyk J, Leszczyszyn-Pynka M, Mach T, Mian M, Knysz B, Horban A: Opportunistic infections and other AIDS-defining illnesses in Poland in 2000-2002. Infection 2006, 34(4):196-200. IF(2012) = 2.440

2005

191. Czyż A, Węgrzyn G: The Obg subfamily of bacterial GTP-binding proteins: essential proteins of largely unknown functions that are evolutionarily conserved from bacteria to humans. Acta Biochimica Polonica 2005, 52:35-43. IF(2012) = 1.185

190. Węgrzyn G: What does “plasmid biology” currently mean? Summary of the Plasmid Biology 2004 Meeting. Plasmid 2005, 53:14-22. IF(2012) = 1.276

189. Podgórska B, Chęć E, Ulanowska K, Węgrzyn G: Optimisation of the microbiological mutagenicity assay based on genetically modified Vibrio harveyi strains. Journal of Applied Genetics 2005, 46:241-246. IF(2012) = 1.847

188. Łyżeń R, Węgrzyn G: Sensitivity of dark mutants of various strains of luminescent bacteria to reactive oxygen species. Archives of Microbiology  2005, 183:203-208. IF(2012) = 1.905

187. Jasiecki J, Węgrzyn G: Localization of Escherichia coli poly(A) polymerase I in cellular membrane. Biochemical and Biophysical Research Communications 2005, 329:598-602. IF(2012) = 2.406

186. Łoś M, Łoś J, Blohm L, Spillner E, Grunwald T, Albers J, Hintsche R, Węgrzyn G: Rapid detection of viruses using electrical biochips and anti-virion sera. Letters in Applied Microbiology 2005, 40:479-485. IF(2012) = 1.629

185. Czyż A, Zielke R, Węgrzyn G: A novel Virbio hraveyi mutant with altered quorum sensing regulation. Oceanological and Hydrobiological Studies 2005, 34:55-61. IF(2012) = 0.400

184. Węgrzyn G, Kurlenda J, Liberek A, Tylki-Szymańska A, Czartoryska B, Piotrowska E, Jakóbkiewicz-Banecka J, Węgrzyn A: Atypical microbial infections of digestive tract may contribute to diarrhea in mucopolysaccharidosis patients: a MPS I case study. BMC Pediatrics 2005, 5:9. IF(2012) = 1.982

183. Jakóbkiewicz-Banecka J, Kloska A, Stepnowska M, Banecki B, Węgrzyn A, Węgrzyn G: A bacterial model for studying effects of human mutations in vivo: Escherichia coli strains mimicking a common polymorphism in the human MTHFR gene. Mutation Research 2005, 578:175-186. IF(2012) = 3.902

182. Iwanicki A, Hinc K, Seror S, Węgrzyn G, Obuchowski M: Transcription in the prpC – yloQ region in Bacillus subtilis. Archives of Microbiology 2005, 183:421-430. IF(2012) = 1.905

181. Piosik J, Gwizdek-Wiśniewska A, Ulanowska K, Ochociński J, Czyż A, Węgrzyn G: Methylxanthines (caffeine, pentoxifylline and theophylline) decrease the mutagenic effect of daunomycin, doxorubicin and mitoxantrone.  Acta Biochimica Polonica 2005, 52:923-926. IF(2012) = 1.185

180. Kozakiewicz J, Gajewska M, Łyżeń R, Czyż A, Węgrzyn G: Bioluminescence-mediated stimulation of photoreactivation in bacteria. FEMS Microbiology Letters 2005, 250:105-110. IF(2012) = 2.049

179. Ulanowska K, Piosik J, Gwizdek-Wiśniewska A, Węgrzyn G: Formation of stacking complexes between caffeine (1,2,3-trimethylxanthine) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine may attenuate biological effects of this neurotoxin. Bioorganic Chemistry 2005, 33:402-413. IF(2012) = 1.732

178. Węglewska A, Jakóbkiewicz-Banecka J, Węgrzyn G: A modified procedure for quantitative analysis of mtDNA, detecting mtDNA depletion. Journal of Applied Genetics 2005, 46:423-428. IF(2012) = 1.847

177. Kloska A, Bohdanowicz J, Konopa G, Tylki-Szymańska A, Jakóbkiewicz-Banecka J, Czartoryska B, Liberek A, Węgrzyn A, Węgrzyn G: Changes in hair morphology of mucopolysaccharidosis I patients treated with recombinant human-L-iduronidase (laronidase, Aldurazyme). American Journal of Medical Genetics 2005, 139A:199-203. IF(2012) = 2.304

176. Wiercińska-Drapało A, Jaroszewicz J, Flisiak R: Epidemiological characteristics of inflammatory bowel disease in North-Eastern Poland. World J Gastroenterol 2005, 11(17):2630-2633. IF(2012) = 2.547

175. Wiercińska-Drapało A, Flisiak R, Jaroszewicz J, Prokopowicz D: Plasma Interleukin-18 reflects severity of ulcerative colitis. World J Gastroenterol 2005, 28(11):605-8. IF(2012) = 2.547

174. Wiercinska-Drapalo A, Jaroszewicz J, Tarasow E, Flisiak R, Prokopowicz D: Transforming growth factor beta1 and prostaglandin E2 concentrations are associated with bone formation markers in ulcerative colitis patients. Prostaglandins Other Lipid Mediat 2005, 78(1-4):160-8. IF(2012) = 2.422

2004

173. Gabig-Cimińska M, Łoś M, Holmgren A, Albers J, Czyż A, Hintsche R, Węgrzyn G, Enfors S-O: Detection of bacteriophage infection and prophage induction in bacterial cultures by means of electric DNA chips. Analytical Biochemistry 2004, 324:84-91. IF(2012) = 2.582

172. Łoś M, Czyż A, Sell E, Węgrzyn A, Neubauer P, Węgrzyn G: Bacteriophage contamination: is there a simple method to reduce its deleterious effects in laboratory cultures and biotechnological factories? Journal of Applied Genetics 2004, 45:111-120. IF(2012) = 1.847

171. Gabig-Cimińska M, Holmgren A, Andresen H, Barken KB, Wumpelmann M, Albers J, Hintsche R, Breitenstein A, Neubauer P, Łoś M, Czyż A, Węgrzyn G, Silfversparre G, Jurgen B, Schweder T, Enfors S-O: Electric chips for rapid detection and quantification of nucleic acids. Biosensors and Bioelectronics 2004, 19:537-546. IF(2012) = 5.437

170. Kędzierska B, Lee DJ, Węgrzyn G, Busby SJW, Thomas MS: Role of the RNA polymerase subunits in CII-dependent activation of the bacteriophagepE promoter: identification of important residues and positioning of the C-terminal domains. Nucleic Acids Research 2004, 32:834-841. IF(2012) = 8.278

169. Węgrzyn G, Węgrzyn A, Tylki-Szymańska A: A general model for genetic regulation of turnover of glycosaminoglycans suggests a possible procedure for prediction of severity and clinical progress of mucopolysaccharidoses. Medical Hypotheses 2004, 62:986-992. IF(2012) = 1.054

168. Katsev AM, Węgrzyn G, Szpilewska H: Effects of hydrogen peroxide on light emission by various strains of marine luminescent bacteria.  Journal of Basic Microbiology 2004, 44:178-184. IF(2012) = 1.198

167. Potrykus K, Wegrzyn G, Hernandez VJ: Direct stimulation of thepaQ promoter by the transcription effector guanosine-3’,5’-(bis)pyrophosphate in a defined in vitro system. J ournal of Biological Chemistry 2004, 279:19860-19866. IF(2012) = 4.651

166. Potrykus J, Węgrzyn G: The ypdI gene codes for a putative lipoprotein involved in the synthesis of colanic acid in Escherichia coli. FEMS Microbiology Letters 2004, 235:265-271. IF(2012) = 2.049

165. Wiercińska-Drapało A, Flisiak J, Jaroszewicz J: Increased plasma TGF-β1 is associated with disease progression in HIV-1 infected patients. Viral Immunology 2004, 17(1):109-13. IF(2012) =  1.75

164. Tarasów E, Wiercińska-Drapało A, Jaroszewicz J, Siergiejczyk J, Orzechowska-Bobkiewicz A, Prokopowicz D, Walecki J: Metabolic disturbances in liver 1H MR spectroscopy in HIV and HCV co-infected patients as a potential marker of hepatocyte activation. Acta Radiol 2004, 45(8):803-9.  IF(2012) = 1.330

163.Tarasów E, Wiercińska-Drapało A, Jaroszewicz J, Orzechowska-Bobkiewicz A, Dzienis W, Prokopowicz D, Walecki J: Antiretroviral therapy and its influence on the stage of brain damage in patients with HIV – 1H MRS evaluation. Med Sci Monitor 2004, 10, supl 3:101–6. IF(2012) = 1.358

162. Wiercińska-Drapało A, Jaroszewicz J, Flisiak R, Prokopowicz D: Plasma interleukin-18 is associated with viral load and disease progression in HIV-1 infected patients. Microbes Infect 2004, 6 (14):1273-77. IF(2012) = 2.920

2003

161. Skowron PM, Majewski J, Żylicz-Stachula A, Rutkowska SR, Jaworowska I, Harasimowicz-Słowińska R: A new Thermus sp. class-IIS enzymes subfamily: isolation of a "twin" restriction endonuclease TspDTI, with a novel specificity 5`-ATGAA(N11/9)-3` related to TspGWI, TaqII and Tth111II. Nucleic Acid Research 2003, 31:e74. IF(2012) = 8.28

160. Guzow-Krzemińska B, Węgrzyn G: A preliminary study on the phylogeny of the genus Melanelia using nuclear large subunit ribosomal DNA sequences. Lichenologist  2003, 35:83-86. IF(2012) = 1.135

159. Czyż A, Kowalska W, Węgrzyn G: Vibrio harveyi mutagenicity assay as a preliminary test for detection of mutagenic pollution of marine water. Bulletin of Environmental Contamination and Toxicology 2003, 70:1065-1070. IF(2012) = 1.105

158. Czyż A, Plata K, Węgrzyn G: Stimulation of DNA repair as an evolutionary drive for bacterial luminescence. Luminescence 2003, 18:140-144. IF(2012) = 1.273

157. Słomińska M, Konopa G, Ostrowska J, Kędzierska B, Węgrzyn G, Węgrzyn A: SeqA-mediated stimulation of a promoter activity by facilitating functions of a transcription activator. Molecular Microbiology 2003, 47:1669-1679. IF(2012) = 4.961

156. Jasiecki J, Węgrzyn G: Growth-rate-dependent RNA polyadenylation in Escherichia coli. EMBO Reports 2003, 4:172-177. IF(2012) = 7.189

155. Słomińska M, Wahl A, Węgrzyn G, Skarstad K: The degradation of mutant initiator protein DnaA204 by proteases ClpP, ClpQ and Lon is prevented when DNA is SeqA-free. Biochemical Journal 2003, 370:867-871. IF(2012) = 4.654

154. Szpilewska H, Czyż A, Węgrzyn G: Experimental evidence for the physiological role of bacterial luciferase in the protection of cells against oxidative stress. Current Microbiology 2003, 47:379-382. IF(2012) = 1.52

153. Słomińska M, Konopa G, Barańska S, Węgrzyn G, Węgrzyn A: Interplay between DnaA and SeqA proteins during regulation of bacteriophage pR promoter activity. Journal of Molecular Biology 2003, 329:59-68. IF(2012) = 3.905

152. Ulanowska K, Sikora A, Węgrzyn G, Czyż A: Role of the cgtA gene function in DNA replication of extrachromosomal elements in Escherichia coli. Plasmid 2003, 50:45-52. IF(2012) = 1.276

151. Wróbel B, Słomiński B, Węgrzyn G: The optimal eukaryotic signal for translation initiation from non-AUG codons, present upstream of bacteriophageP cistron, in inactive in Escherichia coli.  Cellular and Molecular Biology Letters 2003, 8:305-310. IF(2012) = 1.953

150. Glinkowska M, Majka J, Messer W, Węgrzyn G: The mechanism of regulation of bacteriophagepR promoter activity by Escherichia coli DnaA protein. Journal of Biological Chemistry 2003, 278:22250-22256. IF(2012) = 4.651

149. Zielke R, Sikora A, Dutkiewicz R, Węgrzyn G, Czyż A: Involvement of the cgtA gene function in stimulation of DNA repair in Escherichia coli and Vibrio harveyi.  Microbiology  2003, 149:1763-1770. IF(2012) = 2.852

148. Kędzierska B, Glinkowska M, Iwanicki A, Obuchowski M, Sojka P, Thomas MS, Węgrzyn G: Toxicity of the bacteriophagecII gene product to Escherichia coli arises from inhibition of host cell DNA replication. Virology  2003, 313:622-628. IF(2012) = 3.367

147. Szalewska-Pałasz A, Strzelczyk B, Herman-Antosiewicz A, Węgrzyn G, Thomas MS: Genetic analysis of bacteriophage lambda N-dependent antitermination suggests a possible role for the RNA polymerase alpha subunit in facilitating specific functions of NusA and NusE. Archives of Microbiology 2003, 180:161-168.  IF(2012) = 1.905

146. Łoś M, Węgrzyn G, Neubauer P: A role for bacteriophage T4 rI gene function in the control of phage development during pseudolysogeny and in slowly growing host cells. Research in Microbiology 2003, 154:547-552. IF(2012) = 2.889

145. Piosik J, Ulanowska K, Gwizdek-Wiśniewska A, Czyż A, Kapuściński J, Węgrzyn G: Alleviation of mutagenic effects of polycyclic aromatic agents (quinacrine mustard, ICR-191 and ICR-170) by caffeine and pentoxifylline. Mutation Research 2003, 530:47-57. IF(2012) = 3.902

144. Strzelczyk B, Słomińska-Wojewódzka M, Węgrzyn G, Węgrzyn A: Non-random distribution of GATC sequences in regions of promoters stimulated by the SeqA protein of Escherichia coli. Acta Biochimica Polonica 2003, 50:941-945. IF(2012) = 1.185

143. Potrykus J, Węgrzyn G: The acrAB locus is involved in modulating intracellular acetyl coenzyme A levels in a strain of Escherichia coli CM2555 expressing the chloramphenicol acetyltransferase (cat) gene. Archives of Microbiology  2003, 180:362-366. IF(2012) = 1.905

142. Węgrzyn G, Czyż A: Detection of mutagenic pollution of natural environment using microbiological assays. Journal of Applied Microbiology 2003, 95:1175-1181. IF(2012) = 2.196

141. Wiercińska-Drapało A, Flisiak R, Prokopowicz D: Plasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 as biomarkers of ulcerative colitis activity. World J Gastroenterol 2003, 9(12):2843-5. IF(2012) = 2.547

140. Tarasów E, Wiercińska-Drapało A, Kubas B, Dzienis W, Orzechowska-Bobkiewicz A, Prokopowicz D, Walecki J: Cerebral MR spectroscopy in neurologically asymptomatic HIV-infected patients. Acta Radiol 2003, 44:206-12 IF(2012) = 1.330

139. Kubas B, Tarasów E, Wiercińska-Drapało A, Prokopowicz D, Walecki J: Serial MR and MRS examination in a patient with HIV-encephalitis. European Radiology 2003, Vol. 13 suppl. 1; European Congress of Radiology, Vienna, 7-11 March, 2003. s. 521  IF(2012) = 3.548

138. Kuczyński W, Wiercińska-Drapało A: Ciąża po inseminacji domacicznej nasieniem seropozytywnego (HIV-1) partnera – opis pierwszego w Polsce przypadku i przegląd piśmiennictwa. Ginekol Pol 2003, 74:317-21. IF(2012) = 0.786

2002

137. Żylicz-Stachula A, Harasimowicz-Słowińska R, Sobolewski I, Skowron PM: TspGWI, a thermophilic class-IIS restriction endonuclease from Thermus sp. recognizes novel asymmetric sequence 5`-ACGGA(N11/9)-3`. Nucleic Acid Research 2002, 30:e33. IF(2012) = 8.28

136. Słomińska M, Konopa G, Węgrzyn G, Czyż A: Impaired chromosome partitioning and synchronisation of DNA replication initiation in a Vibrio harveyi insertional mutant in the cgtA gene coding for a common GTP-binding protein. Biochemical Journal  2002, 362:579-584. IF(2012) = 4.654

135. Wróbel B, Wegrzyn G: Evolution of lambdoid replication modules.Virus Genes 2002, 24:163-171. IF(2012) = 1.769

134. Wang Z, Le G, Shi Y, Węgrzyn G, Wróbel B: A model for regulation of ColE1-like plasmid replication by uncharged tRNAs in amino acid starved Escherichia coli. Plasmid 2002, 47:69-78. IF(2012) = 1.276

133. Wang Z, Le G, Shi Y, Węgrzyn G: Purification of plasmid DNA using a multicompartment electrolyser separated by ultrafilter membranes. Biotechnology Letters 2002, 24:121-124. IF(2012) = 1.853

132. Gabig M, Herman-Antosiewicz A, Kwiatkowska M, Łoś M, Thomas MS, Węgrzyn G: The cell surface protein Ag43 facilitates phage infection of Escherichia coli in the presence of bile salts and carbohydrates. Microbiology  2002, 148:1533-1542. IF(2012) = 2.852

131. Barańska S, Konopa G, Węgrzyn G: Directionality of plasmid DNA replication carried out by the heritable replication complex. Nucleic Acids Research 2002, 30:1176-1181. IF(2012) = 8.278

130. Potrykus K, Perżyło E, Węgrzyn G: pO, a promoter for oop RNA synthesis, has a role in replication of plasmids derived from bacteriophage. Plasmid 2002, 47:210-215. IF(2012) = 1.276

129. Sikora-Borgula A, Słomińska M, Trzonkowski P, Zielke R, Myśliwski A, Węgrzyn G, Czyż A: A role for the common GTP-binding protein in coupling of chromosome replication to cell growth and cell division. Biochemical and Biophysical Research Communications 2002, 292:333-338. IF(2012) = 2.406

128. Potrykus K, Barańska S, Węgrzyn A, Węgrzyn G: Composition of theplasmid heritable replication complex. Biochemical Journal 2002, 364:857-862. IF(2012) = 4.654

127. Wang Z, Le G, Shi Y, Węgrzyn G: Studies on recovery plasmid DNA from Escherichia coli by heat treatment. Process Biochemistry 2002, 38:199-206. IF(2012) = 2.414

126. Węgrzyn G, Thomas MS: Modulation of the susceptibility of intestinal bacteria to bacteriophages in response to Ag43 phase variation – a hypothesis. Medical Science Monitor 2002, 8:HY15-18. IF(2012) = 1.358

125. Potrykus J, Barańska S, Węgrzyn G: Inactivation of the acrA gene is partially responsible for chloramphenicol sensitivity of Escherichia coli CM2555 strain expressing the chloramphenicol acetyltransferase gene. Microbial Drug Resistance 2002, 8:179-185. IF(2012) = 2.364

124. Czyż A, Plata K, Węgrzyn G: Induction of light emission by luminescent bacteria treated with UV light and chemical mutagens.  Journal of Applied Genetics 2002, 43:377-389. IF(2012) = 1.847

123. Czyż A, Szpilewska H, Dutkiewicz R, Kowalska W, Biniewska-Godlewska A, Węgrzyn G: Comparison of the Ames test and a newly developed assay for detection of mutagenic pollution of marine environments. Mutation Research 2002, 519:67-74. IF(2012) = 2.22

122. Węgrzyn G, Węgrzyn A: Stress responses and replication of plasmids in bacterial cells.Microbial Cell Factories 2002, 1:2. IF(2012) = 3.306

121. Potrykus K, Santos S, Lemonnier M, Diaz-Orejas R, Węgrzyn G: Differential effects of Kid toxin on two modes of replication of lambdoid plasmids suggest that this toxin acts before, but not after, the assembly of the replication complex. Microbiology 2002, 148:2489-2495. IF(2012) = 2.852

120. Dutkiewicz R, Słomińska M, Węgrzyn G, Czyż A: Overexpression of the cgtA (yhbZ, obgE) gene, coding for an essential GTP-binding protein, impairs the regulation of chromosomal functions in Escherichia coli. Current Microbiology 2002, 45:440-445. IF(2012) = 1.52

119. Kijewska A, Rokicki J, Sitko J, Węgrzyn G: Ascaridoidea: a simple DNA assay for identification of eleven species infecting marine and freshwater fish, mammals and fish-eating birds. Experimental Parasitology 2002, 101:35-39. IF(2012) = 2.154

118. Węgrzyn G, Czyż A: How do marine bacteria produce light, why are they luminescent, and can we employ bacterial bioluminescence in aquatic biotechnology? Oceanologia 2002, 44:291-305. IF(2012) = 1.024

117. Potrykus K, Węgrzyn G, Hernandez VJ: Multiple mechanisms of transcription inhibition by ppGpp at the lambda PR promoter. Journal of Biological Chemistry 2002, 277:43785-43791. IF(2012) = 4.651

 

2001

116. Latała B , Obuchowski M, Węgrzyn G: Bacteriophage cIII gene product has an additional function apart from inhibition of cII degradation. Virus Genes 2001, 22:127-132. IF(2012) = 1.769

115. Czyż A, Zielke R, Konopa G, Węgrzyn G: Vibrio harveyi insertional mutant in the cgtA (obg, yhbZ) gene, whose homologues are present in diverse organisms ranging from bacteria to humans and are essential genes in many bacterial species.  Microbiology 2001, 147:183-191. IF(2012) = 2.852

114. Barańska S, Gabig M, Węgrzyn A, Konopa G, Herman-Antosiewicz A, Hernandez P, Schvartzman JB, Helinski DR, Węgrzyn G: Regulation of the switch from early to late bacteriophageDNA replication mode. Microbiology  2001 , 147:535-547. IF(2012) = 2.852

113. Węgrzyn A, Węgrzyn G: Inheritance of the replication complex: a unique or common phenomenon in the control of DNA replication? Archives of Microbiology  2001, 175:86-93. IF(2012) = 1.905

112. Herman-Antosiewicz A, Obuchowski M, Węgrzyn G: A plasmid cloning vector with precisely regulatable copy number in Escherichia coli. Molecular Biotechnology  C 2001, 17:193-199. IF(2012) = 2.262

111. Messer W, Blaesing F, Jakimowicz D, Majka J, Nardmann J, Schaper S, Seitz H, Speck Ch, Weigel Ch, Węgrzyn G, Welzeck M, Zakrzewska-Czerwińska J: Bacterial replication initiator DnaA. Rules for DnaA binding and roles of DnaA in origin unwinding and helicase loading. Biochimie 2001, 83:5-12. IF(2012) = 3.142

110. Jasiecki J, Czyż A, Gabig M, Węgrzyn G: Construction and use of a broad-host-range plasmid expressing the lamB gene for utilization of bacteriophage vectors in the marine bacterium Vibrio harveyi. Marine Biotechnology  2001, 3:336-345. IF(2012) = 2.739

109. Wang Z, Le G, Shi Y, Węgrzyn G: Medium design for plasmid DNA production based on stoichiometric model. Process Biochemistry  2001, 36:1085-1093. IF(2012) = 2.414

108. Czyż A, Zielke R, Węgrzyn G: Rapid degradation of bacteriophageO protein by ClpP/ClpX protease influences the lysis-versus-lysogenization decision of the phage under certain growth conditions of the host cells. Archives of Virology  2001, 146:1487-1498. IF(2012) = 2.03

107. Glinkowska M, Konopa G, Węgrzyn A, Herman-Antosiewicz A, Weigel Ch, Seitz H, Messer W, Węgrzyn G: The double mechanism of incompatibility between plasmids and Escherichia coli dnaA(ts) host cells. Microbiology  2001, 147:923-1928. IF(2012) = 2.852

106. Słomińska M, Węgrzyn A, Konopa G, Skarstad K, Węgrzyn G: SeqA, the Escherichia coli origin sequestration protein, is also a specific transcription factor.  Molecular Microbiology  2001, 40:1371-1380. IF(2012) = 4.961

105. Czyż A, Łoś M, Wróbel B, Węgrzyn G: Inhibition of spontaneous induction of lambdoid prophages in Escherichia coli cultures: simple procedures with possible biotechnological applications. BMC Biotechnology  2001, 1:1. IF(2012) = 2.165

104. Węgrzyn G: The minimal genome paradox. Journal of Applied Genetics 2001, 42:385-392. IF(2012) = 1.847

103. Gabig M, Węgrzyn G: An introduction to DNA chips: principles, technology, applications and analysis.  Acta Biochimica Polonica 2001, 48:615-622. IF(2012) = 1.185

102. Potrykus J, Węgrzyn G: Chloramphenicol-sensitive Escherichia coli strain expressing the chloramphenicol acetyltransferase (cat) gene.  Antimicrobial Agents and Chemotherapy  2001, 45:3610-3612. IF(2012) = 4.565

101. Wiercińska-Drapało A, Flisiak R, Prokopowicz D: Effect of ulcerative colitis activity on plasma concentration of transforming growth factor beta (1). Cytokine 2001, 14(6):343-6. IF(2012) = 2.518

2000

100. Czyż A, Wróbel B, Węgrzyn G: Vibrio harveyi bioluminescence plays a role in stimulation of DNA repair. Microbiology  2000, 146:283-288. IF(2012) = 2.852

99. Jakimowicz D, Majka J, Lis B, Konopa G, Węgrzyn G, Messer W, Schrempf H, Zakrzewska-Czerwińska J: Structure and regulation of the dnaA promoter region of three Streptomyces species. Molecular and General Genetics 2000, 262:1093-1102. IF(2012) = 2.881

98. Czyż A, Jasiecki J, Bogdan A, Szpilewska H, Węgrzyn G: Genetically modified Vibrio harveyi strains as potential bioindicators of mutagenic pollution of marine environments. Applied and Environmental Microbiology  2000, 66:599-605. IF(2012) = 3.678

97. Potrykus K, Wróbel B, Węgrzyn A, Węgrzyn G: Replication of oriJ-based plasmid DNA during the stringent and relaxed responses of Escherichia coli. Plasmid 2000, 44:11-126. IF(2012) = 1.276

96. Jakimowicz D, Majka J, Konopa G, Węgrzyn G, Messer W, Schrempf H, Zakrzewska-Czerwińska J: Architecture of the Sterptomyces lividans DnaA protein-replication origin complexes.J ournal of Molecular Biology  2000, 298:351-364. IF(2012) = 3.905

95. Konopa G, Barańska S, Węgrzyn A, Węgrzyn G: Bacteriophage and host mutants causing the rolling-circle DNA replication early after infection. FEBS Letters  2000, 472:217-220. IF(2012) = 3.582

94. Węgrzyn A, Węgrzyn G: Formation and stability of bacteriophagereplication complexes in UV-irradiated Escherichia coli. Current Microbiology  2000, 41:157-160. IF(2012) = 1.52

93. Węgrzyn A, Czyż A, Gabig M, Węgrzyn G: ClpP/ClpX-mediated degradation of the bacteriophageO protein and regulation of phage and plasmid replication. Archives of Microbiology  2000, 174:89-96. IF(2012) = 1.905

92. Guzow-Krzemińska A, Węgrzyn G: Potential use of restriction analysis of PCR-amplified DNA fragments in construction of molecular data-based identification keys of lichens. Mycotaxon  2000, 76:305-313. IF(2012) = 0.821

91. Kijewska A, Słomińska M, Węgrzyn G, Rokicki J: A PCR-RFLP assay for identification of Anisakis simplex from different geographical regions. Molecular and Cellular Probes  2000, 14:349-354. IF(2012) = 1.873

1999

90. Rutkowska SM, Skowron PM: Rapid screening of elution conditions prior to immunopurification of proteins. BioTechniques 1999, 27:929-932. IF(2012) = 2.4

89. Kaczorowski T, Sęktas M, Skowron PM, Podhajska AJ: The FokI methyltransferase from Flavobacterium okeanokoites. Purification and characterization of the enzyme and its truncated derivatives. Molecular Biotechnology 1999, 13:1-15. IF(2012) = 2.26

88. Węgrzyn G: Replication of plasmids during bacterial response to amino acid starvation. Plasmid 1999, 41:1-16. IF(2012) = 1.276

87. Glinkowska M, Węgrzyn A, Węgrzyn G: Replication of bacteriophage in the Escherichia coli dnaA rac hosts. Genetics 1999, 151:1633-1635. IF(2012) =  4.311

86. Śrutkowska S, Caspi R, Gabig M, Węgrzyn G: Detection of DNA replication intermediates after two-dimensional agarose gel electrophoresis using a fluorescein-labeled probe. Analytical Biochemistry 1999, 269:221-222. IF(2012) = 2.582

85. Węgrzyn A, Wróbel B, Węgrzyn G: Altered biological properties of cell membranes in Escherichia coli dnaA and seqA mutants. Molecular and General Genetics 1999, 261:762-769. IF(2012) = 2.881

84. Konopa G, Szalewska-Pałasz A, Schmidt A, Śrutkowska S, Messer W, Węgrzyn G: The presence of two DnaA-binding sequences is required for efficient interaction of the Escherichia coli DnaA protein with each particular weak DnaA box region. FEMS Microbiology Letters 1999, 174:25-31. IF(2012) = 2.049

83. Kędzierska S, Staniszewska M, Potrykus J, Węgrzyn G: The effect some antibiotic-resistance-conferring plasmids on the removal of the heat-aggregated proteins from Escherichia coli. FEMS Microbiology Letters 1999, 176:279-284.  IF(2012) = 2.049

82. Herman-Antosiewicz A, Węgrzyn G: Regulation of copy number and stability of phagederived pTC1 plasmid in the light of the dimer/multimer catastrophe hypothesis. FEMS Microbiology Letters 1999, 176:489-493. IF(2012) = 2.049

81. Słomińska M, Neubauer P, Węgrzyn G: Regulation of bacteriophage development by guanosine 5'-diphosphate-3'-diphosphate.Virology  1999, 262:431-441. IF(2012) = 3.367

80. Messer W, Blaesing F, Majka J, Nardmann J, Schaper S, Schmidt A, Seitz H, Speck Ch, Tungler D, Węgrzyn G, Weigel Ch, Welzeck M, Zakrzewska-Czerwińska J: Functional domains of DnaA proteins. Biochimie 1999, 81:819-825. IF(2012) = 3.142

79. Wiercińska-Drapało A, Flisiak R, Prokopowicz D. Różyczka jako problem kobiet w wieku rozrodczym. Ginekol Pol 1999, 70(11):815-18. IF(2012) = 0.786

 

1998

78. Swaminathan N, McMaster K, Skowron PM, Mead DA: Thermal cycle labeling: zeptomole detection sensitivity and microgram probe amplification using CviJI* restriction-generated oligonucleotides. Analytical Biochemistry 1998, 255:133-141. IF(2012) = 2.58

73. Wróbel B, Murphy H, Cashel M, Węgrzyn G: Guanosine tetraphosphate (ppGpp)-mediated inhibition of the activity of the bacteriophagepR promoter in Escherichia coli. Molecular and General Genetics 1998, 257:490-495. IF(2012) = 2.881

72. Wróbel B, Węgrzyn G: Replication regulation of ColE1-like plasmids in amino acid-starved Escherichia coli. Plasmid 1998, 39:48-62. IF(2012) = 1.276

71. Gabig M, Obuchowski M, Ciesielska A, Latała B, Węgrzyn A, Thomas MS, Węgrzyn G: The Escherichia coli RNA polymerasesubunit and transcriptional activation by bacteriophageCII protein. Acta Biochimica Polonica 1998, 45:271-280. IF(2012) = 1.185

70. Węgrzyn A, Herman-Antosiewicz A., Taylor K, Węgrzyn G: Molecular mechanism of heat shock-provoked disassembly of the coliphage replication complex. Journal of Bacteriology 1998, 180: 2475-2483. IF(2012) = 3.194

69. Szalewska-Pałasz A, Węgrzyn A, Błaszczak A, Taylor K, Węgrzyn G: DnaA-stimulated transcriptional activation of ori: Escherichia coli RNA polymerasesubunit as a transcriptional activator contact site. Proceedings of the National Academy of Science of USA 1998, 95:4241-4246. IF(2012) = 9.737

68. Śrutkowska S, Konopa G, Węgrzyn G: A method for isolation of plasmid DNA replication intermediates from unsynchronized bacterial cultures for electron microscopy analysis.Acta Biochimica Polonica 1998, 45:233-240. IF(2012) = 1.185

67. Wróbel B, Śrutkowska S, Węgrzyn G: Biochemical and genetic analysis of W, the newly isolated lambdoid phage. Acta Biochimica Polonica 1998, 45:251-259. IF(2012) = 1.185

66. Gabig M, Obuchowski M, Śrutkowska S, Węgrzyn G: Regulation of replication of phage and plasmid at low temperature. Molecular and General Genetics 1998, 258:494-502. IF(2012) = 2.881

65. Wróbel B, Herman-Antosiewicz A, Szalewska-Pałasz A, Węgrzyn G: Polyadenylation of oop RNA in the regulation of bacteriophage development. Gene 1998, 212:57-65. IF(2012) = 2.196

64. Herman-Antosiewicz A, Śrutkowska S, Taylor K, Węgrzyn G: Replication and maintenance of plasmids devoid of the Cro repressor autoregulatory loop in Escherichia coli. Plasmid 1998, 40:113-125. IF(2012) = 1.276

63. Węgrzyn A, Węgrzyn G: Random inheritance of the replication complex by one of two daughter plasmid copies after a replication round in Escherichia coli. Biochemical and Biophysical Research Communications 1998, 246:634-639. IF(2012) = 2.406

62. Gabig M, Obuchowski M, Węgrzyn A, Szalewska-Pałasz A, Thomas MS, Węgrzyn G: Excess production of phagedelayed early proteins under conditions supporting high Escherichia coli growth rates. Microbiology 1998, 144:2217-2224. IF(2012) = 2.852

61. Herman-Antosiewicz A, Węgrzyn G: Replication of plasmid DNA in the Escherichia coli cell cycle. Biochemical and Biophysical Research Communications 1998, 247:554-557. IF(2012) = 2.406

60. Herman-Anotsiewicz A, Węgrzyn A, Taylor K, Węgrzyn G: DnaA-mediated regulation of phage-derived replicons in the absence of pR and Cro function. Virology 1998, 249:98-107. IF(2012) = 3.367

59. Szalewska-Pałasz A, Wróbel B, Węgrzyn G: Rapid degradation of polyadenylated oop RNA. FEBS Letters 1998, 432:70-72. IF(2012) = 3.582

58. Szalewska-Pałasz A, Weigel Ch, Speck Ch, Śrutkowska S, Konopa G, Lurz R, Marszałek J, Taylor K, Messer W, Węgrzyn G: Interaction of the Escherichia coli DnaA protein with bacteriophage DNA. Molecular and General Genetics 1998, 259:679-688. IF(2012) = 2.881

57. Szalewska-Pałasz A, Lemieszek E, Pankiewicz A, Węgrzyn A, Helinski DR, Węgrzyn G: Escherichia coli dnaA gene function and bacteriophage replication. FEMS Microbiology Letters 1998, 167:27-32. IF(2012) = 2.049

56. Węgrzyn A, Szalewska-Pałasz A, Błaszczak A, Liberek K, Węgrzyn G: Differential inhibition of transcription from 70- and 32-dependent promoters by rifampicin. FEBS Letters 1998, 440: 172-174.  IF(2012) = 3.582

55. Wiercińska-Drapało A, Grzeszczuk A, Panasiuk A, Prokopowicz D: Babezjoza, choroba ludzi i zwierząt. Pol Arch Med Wewn 1998, 3:239-44. IF(2012) = 1.833

54. Rogowska-Szadkowska D, Borzuchowska A, Wiercińska-Drapało A, Chlabicz S. Profilaktyka po zawodowej ekspozycji na ludzki wirus upośledzenia odporności/HIV. Pol Arch Med Wewn  1997, 98:431-40. IF(2012) = 1.833

53. Wiercińska-Drapało A, Rogowska-Szadkowska D, Prokopowicz D. Co skłania ludzi do wykonywania testów anty-HIV. Pol Arch Med Wewn 1998, 99:403-6. IF(2012) = 1.833

1997

52. Obuchowski M, Węgrzyn A, Szalewska-Pałasz A, Thomas MS, Węgrzyn G: An RNA polymerasesubunit mutant impairs N-dependent transcriptional antitermination in Escherichia coli. Molecular Microbiology  1997, 23:211-222. IF(2012) = 4.961

51. Obuchowski M, Giladi H, Koby S, Szalewska-Pałasz A, Węgrzyn A, Oppenheim AB, Thomas MS, Węgrzyn G: Impaired lysogenisation of the Escherichia coli rpoA341 mutant by bacteriophageis due to the inability of CII to act as a transcriptional activator. Molecular and General Genetics  1997, 254:304-311. IF(2012) = 2.881

50. Wróbel B, Węgrzyn G: Replication and amplification of plasmids in Escherichia coli during amino acid starvation and limitation. FEMS Microbiology Letters 1997, 153:151-157. IF(2012) = 2.049

49. Wróbel B, Węgrzyn G: Differential amplification efficiency of pMB1 and p15A (ColE1-type) replicons in Escherichia coli stringent and relaxed strains starved for particular amino acids. Microbiological Research 1997, 152:251-255. IF(2012) = 1.993

48. Wróbel B, Węgrzyn G: Replication of plasmids derived from P1, F, R1, R6K and RK2 replicons in amino acid-starved Escherichia coli stringent and relaxed strains. Journal of Basic Microbiology  1997, 37:451-463. IF(2012) = 1.198

46. Obuchowski M, Shotland Y, Koby S, Giladi H, Gabig M, Węgrzyn G, Oppenheim AB: Stability of CII is a key element in the cold stress response of bacteriophage infection. Journal of Bacteriology 1997, 179:5987-5991. IF(2012) = 3.194

46. Mikiewicz D, Wróbel B, Węgrzyn G, Płucienniczak A: Isolation and characterization of a ColE1-like plasmid from Enterobacter agglomerans with a novel variant of rom gene. Plasmid  1997, 38: 210-219. IF(2012) = 1.276

45. Wróbel B, Węgrzyn G: Amplification of pSC101 replicons in Escherichia coli during amino acid limitation. Journal of Biotechnology  1997, 58:205-208. IF(2012) = 3.183

1996

44. Swaminathan N, Mead D, McMaster K, George D, Van Etten JL, Skowron PM: Molecular cloning of the three base restriction endonuclease R.CviJI from eukaryotic Chlorella virus IL-3A. Nucleic Acid Research 1996, 24:2463-2469. IF(2012) = 8.28

43. Skowron PM, Harasimowicz R, Rutkowska SM: GCN4 eucaryotic transcription factor/FokI endonuclease mediated `Achilles Heel Cleavage`: quantitative study of protein-DNA interaction. Gene 1996, 170:1-8. IF(2012) = 2.196

42. Lee JH, Skowron PM, Rutkowska SM, Hong SS, Kim SC: Sequential amplification of cloned DNA as tandem multimers using class-IIS restriction endonucleases. Genetic Analysis: Biomolecular Engineering 1996, 13:139-145. IF(2009) = 3.172

41. Kim SC, Skowron PM, Szybalski W: Structural requirements for FokI-DNA interaction and oligodeoxyribonucleotide-instructed cleavage. J. Molecular Biology 1996, 258:638-649. IF(2012) = 3.905

40. Węgrzyn A, Węgrzyn G, Taylor K: Disassembly of the coliphagereplication complex due to heat shock induction of the groE operon. Virology 1996, 217:594-597. If(2012) = 3.367

39. Neubauer P, Wróbel B, Węgrzyn G: DNA degradation at elevated temperatures after plasmid amplification in amino acid-starved Escherichia coli cells.Biotechnology Letters 1996, 18:321-326. IF(2012) = 1.853

38. Obuchowski M, Węgrzyn G: Synthesis of the bacteriophage P protein in amino acid-starved Escherichia coli cells. Biochemical and Biophysical Research Communications 1996, 222:612-618. IF(20120) = 2.406

37. Węgrzyn G, Węgrzyn A, Pankiewicz A, Taylor K: Allele specificity of the Escherichia coli dnaA gene function in the replication of plasmids derived from phage. Molecular and General Genetics 1996, 252:580-586. IF(2012) = 2.881

36. Węgrzyn A, Taylor K, Węgrzyn G: The cbpA chaperone gene function compensates for dnaJ inplasmid replication during amino acid starvation of Escherichia coli. Journal of Bacteriology 1996, 178:5847-5849. IF(2012) = 3.194

35. Szalewska-Pałasz A, Węgrzyn A, Obuchowski M, Pawłowski R, Bielawski K, Thomas MS, Węgrzyn G: Drastically decreased transcription from CII-activated promoters is responsible for impaired lysogenization of the Escherichia coli rpoA341 mutant by bacteriophage. FEMS Microbiology Letters 1996, 144:21-27. IF(2012) = 2.049

34. Węgrzyn A, Węgrzyn G, Herman A, Taylor K: Protein inheritance: plasmid replication perpetuated by the heritable replication complex. Genes to Cells 1996, 1:953-963. IF(2012) = 2.731

33. Czarnowski D, Panasiuk B, Wiercińska-Drapało A, Puzanowska B, Prokopowicz D. Zespół przewlekłego zmęczenia. Pol Arch Med Wewn 1996, 96:161-4. IF(2012) = 1.833

1995

32. Rutkowska SM, Skowron PM, Bielawski K, Podhajska A: SacNI, a novel BanII isoschizomer from Streptomyces achromogenes recognizing 5`-GRGCY/C-3`. Gene 1995, 157:319-320. IF(2012) = 2.196

31. Rutkowska SM, Skowron PM, Podhajska A: Purification and characterization of the restriction endonuclease AvcI from Actinomyces cristalomycini. Gene 1995, 157:317-318. IF(2012) = 2.196

30. Tucholski J, Skowron PM, Podhajska A: MmeI, a class-IIS restriction endonuclease: purification and properties. Gene 1995, 157:87-92. IF(2012) = 2.196

29. Skowron PM, Swaminathan N, McMaster K, George D, Van Etten J, Mead D: Cloning and application of the two/three-base restriction endonuclease R.CviJI from IL-3A virus- infected Chlorella. Gene 1995, 157:37-41. IF(2012) = 2.196

28. Herman A, Węgrzyn G: Effect of increased ppGpp concentration on DNA replication of different replicons in Escherichia coli. Journal of Basic Microbiology 1995, 35:33-39. IF(2012) = 1.198

27. Taylor K, Węgrzyn G: Replication of coliphage lambda DNA. FEMS Microbiology Reviews 1995, 17: 109-119. IF(2012) = 13.231

26. Węgrzyn G, Węgrzyn A, Konieczny I, Bielawski K, Konopa G, Obuchowski M, Helinski DR, Taylor K: Involvement of the host initiator function dnaA in the replication of coliphage. Genetics 1995, 139:1469-1481. IF(2012) =  4.311

25. Węgrzyn G, Szalewska-Pałasz A, Węgrzyn A, Obuchowski M, Taylor K: Transcriptional activation of coliphage DNA replication is regulated by the host DnaA initiator function. Gene 1995, 154:47-50. IF(2012) = 2.196

24. Węgrzyn A, Węgrzyn G, Taylor K: Protection of coliphage O initiator protein from proteolysis in the assembly of the replication complex in vivo. Virology 1995, 207:179-184. If(2012) = 3.367

23. Węgrzyn A, Węgrzyn G, Taylor K: Plasmid and host functions required for plasmid replication carried out by the inherited replication complex. Molecular and General Genetics 1995, 245: 501-508. IF(2012) = 2.881

22. Szalewska-Pałasz A, Węgrzyn G: Inhibition of transcription starting from bacteriophage pR promoter during the stringent response in Escherichia coli: implications for  DNA replication. Acta Biochimica Polonica 1995, 42:233-240. IF(2012) = 1.185

21. Węgrzyn G: Amplification of plasmids in Escherichia coli relA mutants. Journal of Biotechnology 1995, 43:139-143. IF(2012) = 3.183

20. Węgrzyn A, Węgrzyn G: Transcriptional activation of ori regulates plasmid replication in amino acid-starved Escherichia coli cells. Biochemical and Biophysical Research Communications 1995, 214:978-984. IF(2012) = 2.406

1994

19. Herman A, Węgrzyn A, Węgrzyn G: Regulation of replication of plasmid pBR322 in amino acid-starved Escherichia coli strains. Molecular and General Genetics 1994, 243:374-378. IF(2012) =  2.881

18. Herman A, Węgrzyn A, Węgrzyn G: Combined effect of stringent or relaxed response, temperature and rom function on the replication of pUC plasmids in Escherichia coli. Acta Biochimica Polonica 1994, 41:122-124. IF(2012) = 1.185

17. Herman A, Węgrzyn A, Węgrzyn G: Differential replication of plasmids during stringent and relaxed response of Escherichia coli. Plasmid 1994, 32:89-94. IF(2012) = 1.276

16. Szalewska A, Węgrzyn G, Taylor K: Neither absence nor excess of O initiator-digesting ClpXP protease affects plasmid or phage replication in Escherichia coli. Molecular Microbiology  1994, 13:469-474. IF(2012) = 4.961

15. Szalewska-Pałasz A, Węgrzyn A, Herman A, Węgrzyn G: The mechanism of the stringent control of  plasmid DNA replication. EMBO Journal  1994, 13:5779-5785. IF(2012) = 9.822

14. Szalewska-Pałasz A, Węgrzyn G: An additional role of transcriptional activation of ori in the regulation of  plasmid replication in Escherichia coli. Biochemical and Biophysical Research Communications 1994, 205:802-806. IF(2012) = 2.406

1993

13. Skowron PM, Kaczorowski T, Tucholski J, Podhajska A: Atypical DNA-binding properties of class-IIS restriction endonucleases: evidence for recognition of the cognate sequence by a FokI monomer. Gene 1993 125:1-10. IF(2012) = 2.196

12. Pawłowicz A, Węgrzyn G, Taylor K: Effect of coliphageP gene mutations on the stability of the O protein, the initiator of DNA replication. Acta Biochimica Polonica 1993, 40:29-31. IF(2012) = 1.185

11. Salwa A, Węgrzyn G: Izolacja wirusa maedi owiec w Polsce. Medycyna Weterynaryjna 1993, 49: 298-300. IF(2012) = 0,203

1992

10. Fitzgerald MC, Skowron PM, Van Etten JL, Smith LM, Mead DA: Rapid shotgun cloning utilizing the two base recognition endonuclease CviJI. Nucleic Acid Res. 1992, 20:3753-3762. IF(2012) = 8.28

9. Węgrzyn G, Pawłowicz A, Taylor K: Stability of coliphage . DNA replication initiator, the O protein. Journal of Molecular Biology 1992, 226:675-680. IF(2012) = 3.905

8. Węgrzyn G, Taylor K: Inheritance of the replication complex by one of two daughter copies during plasmid replication in Escherichia coli. Journal of Molecular Biology 1992, 226:681-688. IF(2012) = 3.905

7. Węgrzyn G, Glass RE, Thomas MS: Involvement of the Escherichia coli RNA polymerase subunit in transcriptional activation by the bacteriophage lambda CI and CII proteins. Gene 1992, 122:1 IF(2012) = 2.196

1991

6. Piechula S, Skowron PM, Piatyszek M, Podhajska A: Isolation and identification of two new Synechococcus-derived restriction endonucleases, SleI and SspAI, isoschizomers of EcoRII. Nucleic Acid Res. 1991, 19:2782. IF(2012) = 8.28

5. Obuchowski M, Węgrzyn G: Eriochrome black T as a dye for agarose gel electrophoresis. Acta Biochimica Polonica 1991, 38:177-179. IF(2012) = 1.185

4. Węgrzyn G, Kwaśnik E, Taylor K: Replication of plasmid in amino acid-starved strains of Escherichia coli. Acta Biochimica Polonica 1991, 38:181-186. IF(2012) = 1.185

3. Węgrzyn G, Neubauer P, Krueger S, Hecker M, Taylor K: Stringent control of replication of plasmids derived from coliphage. Molecular and General Genetics 1991, 225:94-98. IF(2012) =  2.881

1989

2. Kaczorowski T, Skowron PM, Podhajska AJ: Purification and characterization of the FokI Restriction endonuclease. Gene 1989, 80:209-216. IF(2012) = 2.196

1987

1. Bielawski K, Skowron PM, Kur J, Konopa G, Podhajska A, Taylor K: Construction of a DNA-polymerase I overproducing plasmid and isolation of the enzyme. Acta Biochimica Polonica 1987, 34:29-34. IF(2012) = 1.185

_

 

Partners

 

A PROJECT CO-FINANCED BY THE EUROPEAN UNION FROM THE EUROPEAN REGIONAL DEVELOPMENT FUND GRANTS FOR INNOVATION